<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>OCT-Angiography and Glaucoma - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjW-O1JCfKDcEQKEE7CQAAABE","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"OCT-Angiography_and_Glaucoma","wgTitle":"OCT-Angiography and Glaucoma","wgCurRevisionId":89567,"wgRevisionId":89567,"wgArticleId":15253,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"OCT-Angiography_and_Glaucoma","wgRelevantArticleId":15253,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],
"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,
"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Glaucoma is the first cause of irreversible blindness in the world. Fifty percent of glaucomas are undiagnosed; consequently, we should develop new technologies to aid in glaucoma diagnosis. Optical Coherence Tomography Angiography (OCTA) is a recent, non-invasive and fast technology that allows the visualization of retinal and papillary vessels. Studies have shown that OCTA detects decreased vascular density in glaucoma."/>
<meta name="date" content="2023-02-09"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="OCT-Angiography and Glaucoma" href="/w/index.php?title=Special:ExportRDF/OCT-Angiography_and_Glaucoma&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-OCT-Angiography_and_Glaucoma rootpage-OCT-Angiography_and_Glaucoma layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=OCT-Angiography+and+Glaucoma" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=OCT-Angiography+and+Glaucoma" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzyyutns"></button>
					<div class="collapse navbar-collapse hbpzyyutns" id="hbpzyyutns">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/OCT-Angiography_and_Glaucoma" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:OCT-Angiography_and_Glaucoma&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=OCT-Angiography_and_Glaucoma&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=OCT-Angiography_and_Glaucoma&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=OCT-Angiography_and_Glaucoma&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="OCT-Angiography_and_Glaucoma#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">OCT-Angiography and Glaucoma</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Ana.Miguel" title="User:Ana.Miguel">Ana IM Miguel</a>,&#8201;<a href="/User:Andre.Ferreira" title="User:Andre.Ferreira">André Ferreira, MD</a>,&#8201;<a href="/User:Andre.Silva" title="User:Andre.Silva">André Borges Silva</a>,&#8201;<a href="/User:Helene.Bailleul" title="User:Helene.Bailleul">BAILLEUL Hélène</a>,&#8201;<a href="/User:Joao.F.Barbosa-Breda_MD" title="User:Joao.F.Barbosa-Breda MD">Joao Breda, MD</a>,&#8201;<a href="/User:Luis.Abegao.Pinto" title="User:Luis.Abegao.Pinto">Luis Abegão Pinto, MD, PhD</a>,&#8201;<a href="/User:Rita.Anjos" title="User:Rita.Anjos">Rita Anjos MD</a>,&#8201;<a href="/w/index.php?title=User:Aymen.Mahjoub&amp;action=formedit&amp;redlink=1" class="new" title="User:Aymen.Mahjoub (page does not exist)">Aymen.Mahjoub</a>,&#8201;<a href="/w/index.php?title=User:Benoit.Gandon&amp;action=formedit&amp;redlink=1" class="new" title="User:Benoit.Gandon (page does not exist)">Benoit.Gandon</a>,&#8201;<a href="/w/index.php?title=User:Anais.Lecanuet&amp;action=formedit&amp;redlink=1" class="new" title="User:Anais.Lecanuet (page does not exist)">Anais.Lecanuet</a>,&#8201;<a href="/w/index.php?title=User:Michel.Puech&amp;action=formedit&amp;redlink=1" class="new" title="User:Michel.Puech (page does not exist)">Michel.Puech</a>,&#8201;<a href="/w/index.php?title=User:Jeremy.Legeai&amp;action=formedit&amp;redlink=1" class="new" title="User:Jeremy.Legeai (page does not exist)">Jeremy.Legeai</a>,&#8201;<a href="/w/index.php?title=User:Chloe.Martin&amp;action=formedit&amp;redlink=1" class="new" title="User:Chloe.Martin (page does not exist)">Chloe.Martin</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#160;<a href="/User:Daniel.B.Moore" title="User:Daniel.B.Moore">Daniel B. Moore, MD</a>,&#160;<a href="/User:Ana.Miguel" title="User:Ana.Miguel">Ana IM Miguel</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Daniel.B.Moore" title="User:Daniel.B.Moore">Daniel B. Moore, MD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Up to Date</b>
</div>
</div>&#160;by <a href="/User:Daniel.B.Moore" title="User:Daniel.B.Moore">Daniel B. Moore, MD</a> on February 10, 2023.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=OCT-Angiography_and_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=OCT-Angiography_and_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Article_Summary"><span class="tocnumber">1</span> <span class="toctext">Article Summary</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Disease_Entity:_Glaucoma"><span class="tocnumber">2</span> <span class="toctext">Disease Entity: Glaucoma</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Vascular_and_Mechanical_theories_of_glaucoma"><span class="tocnumber">2.1</span> <span class="toctext">Vascular and Mechanical theories of glaucoma</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Anatomy_-_Vascularization_of_the_optic_nerve"><span class="tocnumber">2.2</span> <span class="toctext">Anatomy - Vascularization of the optic nerve</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#OCT.2C_OCTA_and_glaucoma"><span class="tocnumber">3</span> <span class="toctext">OCT, OCTA and glaucoma</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Historical_considerations_and_functioning_principles_of_OCT_and_OCTA"><span class="tocnumber">3.1</span> <span class="toctext">Historical considerations and functioning principles of OCT and OCTA</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Algorithms_and_devices"><span class="tocnumber">3.2</span> <span class="toctext">Algorithms and devices</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Terminology_in_OCTA"><span class="tocnumber">3.3</span> <span class="toctext">Terminology in OCTA</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Technique_description"><span class="tocnumber">3.4</span> <span class="toctext">Technique description</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#OCTA_and_diagnostics_of_glaucoma"><span class="tocnumber">3.5</span> <span class="toctext">OCTA and diagnostics of glaucoma</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#OCTA_and_longitudinal_studies"><span class="tocnumber">3.6</span> <span class="toctext">OCTA and longitudinal studies</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#OCTA_and_glaucoma_surgery"><span class="tocnumber">3.7</span> <span class="toctext">OCTA and glaucoma surgery</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#OCTA_of_the_anterior_segment"><span class="tocnumber">3.8</span> <span class="toctext">OCTA of the anterior segment</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#OCTA_and_systemic_and_neuro-ophthalmological_diseases"><span class="tocnumber">3.9</span> <span class="toctext">OCTA and systemic and neuro-ophthalmological diseases</span></a>
<ul>
<li class="toclevel-3 tocsection-15"><a href="#OCTA_and_systemic_pathologies"><span class="tocnumber">3.9.1</span> <span class="toctext">OCTA and systemic pathologies</span></a></li>
<li class="toclevel-3 tocsection-16"><a href="#Multiple_sclerosis"><span class="tocnumber">3.9.2</span> <span class="toctext">Multiple sclerosis</span></a></li>
<li class="toclevel-3 tocsection-17"><a href="#Anterior_ischemic_optic_neuropathy"><span class="tocnumber">3.9.3</span> <span class="toctext">Anterior ischemic optic neuropathy</span></a></li>
<li class="toclevel-3 tocsection-18"><a href="#Leber_hereditary_optic_neuropathy"><span class="tocnumber">3.9.4</span> <span class="toctext">Leber hereditary optic neuropathy</span></a></li>
<li class="toclevel-3 tocsection-19"><a href="#Dominant_optic_atrophy"><span class="tocnumber">3.9.5</span> <span class="toctext">Dominant optic atrophy</span></a></li>
<li class="toclevel-3 tocsection-20"><a href="#Optic_disc_swelling"><span class="tocnumber">3.9.6</span> <span class="toctext">Optic disc swelling</span></a></li>
<li class="toclevel-3 tocsection-21"><a href="#Optic_disc_drusen"><span class="tocnumber">3.9.7</span> <span class="toctext">Optic disc drusen</span></a></li>
<li class="toclevel-3 tocsection-22"><a href="#Compressive_optic_neuropathy"><span class="tocnumber">3.9.8</span> <span class="toctext">Compressive optic neuropathy</span></a></li>
<li class="toclevel-3 tocsection-23"><a href="#Radiation_optic_neuropathy"><span class="tocnumber">3.9.9</span> <span class="toctext">Radiation optic neuropathy</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-24"><a href="#Clinical_cases_and_images_of_OCTA_and_glaucoma"><span class="tocnumber">4</span> <span class="toctext">Clinical cases and images of OCTA and glaucoma</span></a>
<ul>
<li class="toclevel-2 tocsection-25"><a href="#Healthy_patient_-_optic_nerve_OCTA"><span class="tocnumber">4.1</span> <span class="toctext">Healthy patient - optic nerve OCTA</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Glaucomatous_patient_-_whole-image_optic_nerve_OCTA"><span class="tocnumber">4.2</span> <span class="toctext">Glaucomatous patient - whole-image optic nerve OCTA</span></a></li>
<li class="toclevel-2 tocsection-27"><a href="#Glaucomatous_versus_healthy_patient_.E2.80.93_whole-image_macular_OCTA"><span class="tocnumber">4.3</span> <span class="toctext">Glaucomatous <i>versus</i> healthy patient – whole-image macular OCTA</span></a></li>
<li class="toclevel-2 tocsection-28"><a href="#Advanced_asymmetric_glaucoma_and_myopia"><span class="tocnumber">4.4</span> <span class="toctext">Advanced asymmetric glaucoma and myopia</span></a></li>
<li class="toclevel-2 tocsection-29"><a href="#OCTA_VD_increase_after_glaucoma_surgery"><span class="tocnumber">4.5</span> <span class="toctext">OCTA VD increase after glaucoma surgery</span></a></li>
<li class="toclevel-2 tocsection-30"><a href="#Two_OCTA_devices_with_the_same_patient"><span class="tocnumber">4.6</span> <span class="toctext">Two OCTA devices with the same patient</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-31"><a href="#Conclusion"><span class="tocnumber">5</span> <span class="toctext">Conclusion</span></a></li>
<li class="toclevel-1 tocsection-32"><a href="#Additional_Resources"><span class="tocnumber">6</span> <span class="toctext">Additional Resources</span></a></li>
<li class="toclevel-1 tocsection-33"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h2><span class="mw-headline" id="Article_Summary">Article Summary</span></h2>
<p>Glaucoma is the first cause of irreversible blindness in the world. Fifty percent of glaucomas are undiagnosed; consequently, we should develop new technologies to aid in glaucoma diagnosis. Optical Coherence Tomography Angiography (OCTA) is a recent, non-invasive and fast technology that allows the visualization of retinal and papillary vessels. Studies have shown that OCTA detects decreased vascular density in glaucoma.
</p>
<h1><span class="mw-headline" id="Disease_Entity:_Glaucoma">Disease Entity: Glaucoma</span></h1>
<p>Glaucoma is an optic neuropathy with typical changes in the optic nerve head, retinal nerve fiber layer, and visual fields<sup id="cite_ref-:0_1-0" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. It is the second leading cause of blindness<sup id="cite_ref-2" class="reference"><a href="#cite_note-2">&#91;2&#93;</a></sup>, which is unfortunately irreversible. Therefore, the diagnosis is critical to prevent blindness. The diagnosis depends on the clinical examination (optic disc, retinal fibers, gonioscopy, intraocular pressure) and complementary exams (visual fields and optical coherence tomography, OCT)<sup id="cite_ref-:0_1-1" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Despite this, approximately 50% of glaucomas are undiagnosed<sup id="cite_ref-3" class="reference"><a href="#cite_note-3">&#91;3&#93;</a></sup><sup id="cite_ref-4" class="reference"><a href="#cite_note-4">&#91;4&#93;</a></sup>.  
</p><p>Consequently, there is a need to develop technology to help diagnose glaucoma. OCT Angiography is a recent, non-invasive and fast technology that allows the visualization of retinal and papillary vessels, which can help to diagnose glaucoma<sup id="cite_ref-:6_5-0" class="reference"><a href="#cite_note-:6-5">&#91;5&#93;</a></sup>. However, before going into the details of OCTA, we should first focus on the vascular theory of glaucoma and vascularization of the optic nerve.
</p>
<h2><span class="mw-headline" id="Vascular_and_Mechanical_theories_of_glaucoma">Vascular and Mechanical theories of glaucoma</span></h2>
<p>The pathophysiology of glaucoma is not yet fully understood, but two theories try to explain the apoptosis of retinal ganglion cells<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">&#91;6&#93;</a></sup>.  
</p><p><b>A. Mechanical theory</b> 
</p><p>The <b>mechanical theory</b> <sup id="cite_ref-7" class="reference"><a href="#cite_note-7">&#91;7&#93;</a></sup> explains apoptosis by disruption of the axonal transport of retinal ganglion cells (RGC) at the lamina cribrosa secondary to relatively elevated intraocular pressure (IOP). The lamina cribrosa becomes thinner and deformed, increasing the Cup / Disc ratio, impeding axoplasmic flow within the optic nerve fibers, ending with RGC apoptosis <sup id="cite_ref-8" class="reference"><a href="#cite_note-8">&#91;8&#93;</a></sup>. Many studies have shown IOP as a risk factor for developing glaucoma and its progression <sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10">&#91;10&#93;</a></sup><sup id="cite_ref-11" class="reference"><a href="#cite_note-11">&#91;11&#93;</a></sup><sup id="cite_ref-:1_12-0" class="reference"><a href="#cite_note-:1-12">&#91;12&#93;</a></sup><sup id="cite_ref-:2_13-0" class="reference"><a href="#cite_note-:2-13">&#91;13&#93;</a></sup><sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup>. Nevertheless, this theory is insufficient to explain glaucoma because many glaucoma patients progress with normal IOP, and many patients have high IOP without developing glaucoma <sup id="cite_ref-:2_13-1" class="reference"><a href="#cite_note-:2-13">&#91;13&#93;</a></sup>. 
</p><p><b>B. Vascular theory</b> 
</p><p>The second theory is the <b>vascular theory</b> <sup id="cite_ref-:1_12-1" class="reference"><a href="#cite_note-:1-12">&#91;12&#93;</a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup><sup id="cite_ref-:3_17-0" class="reference"><a href="#cite_note-:3-17">&#91;17&#93;</a></sup>: decreased ocular blood flow and optic nerve perfusion result in RGC apoptosis, secondary to mechanical effects such as IOP or systemic effects such as cardiovascular risk factors. The hypoperfusion and the loss of vascular autoregulation result in ischemia and oxidative stress <sup id="cite_ref-:4_18-0" class="reference"><a href="#cite_note-:4-18">&#91;18&#93;</a></sup>. 
</p><p><b>Ocular perfusion pressure (OPP)</b> can be defined<sup id="cite_ref-:4_18-1" class="reference"><a href="#cite_note-:4-18">&#91;18&#93;</a></sup> by the difference between arterial pressure (AP) and venous pressure (VP): <b>OPP = AP –VP</b>. Another equation is <b>OPP = 2/3 mean arterial blood pressure – IOP</b>. The intraocular arterial pressure is inaccessible directly, so we use the brachial mean arterial pressure (MAP): <b>MAP = DBP + 1/3 (SBP − DBP)</b>, with SBP = systolic blood pressure and DBP = diastolic blood pressure. 
</p><p>The ocular arterial pressure has a nycthemeral variation, higher at night when lying down. For glaucomatous subjects, the difference between venous pressure and intraocular pressure is increased. Vascular resistance influences blood flow. The mathematical formula describing this resistance is <b>R = (8 × n × l) / (π × r4)</b> with n = blood viscosity, l = vascular length and r = vascular radius. Vascular length is constant in adult human beings; the diameter (radius * 2) remains the main factor controlling blood flow, increasing resistance reduce the blood flow. The loss of this regulatory mechanism can result in ischemia. For example, a 50% decrease in the vascular diameter reduces the flow by 94% <sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup>. Vasoregulators, either constrictors or dilators, control this diameter.
</p><p>The primary vasodilator in the endothelium of the vessels is nitric oxide <sup id="cite_ref-20" class="reference"><a href="#cite_note-20">&#91;20&#93;</a></sup>, which increases the level of cGMP, decreasing the level of intracellular calcium (Ca2 +) and reducing the phosphorylation of the loosening myosin chains. The two most effective mechanisms for creating vasodilation are hypoxia and hypercapnia. Vasodilation due to hypercapnia is seen in the choroid, retina, and optic nerve and is mediated by carbon monoxide and prostaglandins. Vasodilation secondary to hypoxia is observed in the retina. The aqueous humor of glaucomatous patients has increased nitric oxide concentration <sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup>, probably by increased nitric oxide production by inducible NO synthetases in the optic nerve <sup id="cite_ref-:5_22-0" class="reference"><a href="#cite_note-:5-22">&#91;22&#93;</a></sup>. 
</p><p>The main vasoconstrictor is endothelin-1 <sup id="cite_ref-:5_22-1" class="reference"><a href="#cite_note-:5-22">&#91;22&#93;</a></sup>, which is secreted by the endothelium and mediates the two most potent vasoconstriction causes: hyperoxia and hypocapnia. Endothelin-1 is not involved in maintaining ocular basal blood flow in humans (<i>in vitro</i> comparison and measurement with Doppler ultrasound), according to one study <sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup>. 
</p><p>Scientific evidence supports several aspects of the vascular theory. For example, arterial hypertension can correlate <sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup><sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup> with increased IOP, especially over 40 years. An increase in the mean arterial pressure of 10 mmHg was associated with an increase in IOP of 0.2-0.4 mmHg, according one study <sup id="cite_ref-:3_17-1" class="reference"><a href="#cite_note-:3-17">&#91;17&#93;</a></sup>, but not in all. The nychthemeral variation of these two physiological variables also seems correlated <sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup>. Several studies have shown an association between arterial hypotension and primary open-angle glaucoma <sup id="cite_ref-:3_17-2" class="reference"><a href="#cite_note-:3-17">&#91;17&#93;</a></sup><sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup>. Intraocular pressure in glaucomatous patients is also associated with orthostatic arterial hypotension <sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup>. The visual fields in normal-pressure glaucoma have 2.6 times more relative risk of severity if associated with migraine <sup id="cite_ref-31" class="reference"><a href="#cite_note-31">&#91;31&#93;</a></sup>. Raynaud's syndrome is also observed more frequently in normal-pressure glaucoma than in primary open-angle glaucoma <sup id="cite_ref-32" class="reference"><a href="#cite_note-32">&#91;32&#93;</a></sup>.
</p><p>
In conclusion, many studies support different aspects of each theory in glaucoma, but its pathogenesis is not fully understood. </p><div class="thumb tright"><div class="thumbinner" style="width:644px;"><a href="/File:Fig_1_anamiguel_vasc_optic_nerve.png" class="image"><img alt="" src="/w/images/1/thumb/d/d8/Fig_1_anamiguel_vasc_optic_nerve.png/642px-Fig_1_anamiguel_vasc_optic_nerve.png" decoding="async" width="642" height="382" class="thumbimage" srcset="/w/images/1/thumb/d/d8/Fig_1_anamiguel_vasc_optic_nerve.png/963px-Fig_1_anamiguel_vasc_optic_nerve.png 1.5x, /w/images/1/thumb/d/d8/Fig_1_anamiguel_vasc_optic_nerve.png/1284px-Fig_1_anamiguel_vasc_optic_nerve.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_1_anamiguel_vasc_optic_nerve.png" class="internal" title="Enlarge"></a></div>Figure 1. Vascularization of the optic nerve.</div></div></div>
<h2><span class="mw-headline" id="Anatomy_-_Vascularization_of_the_optic_nerve">Anatomy - Vascularization of the optic nerve</span></h2>
<p>We present a brief anatomical review of the optic nerve to understand further how OCTA can aid in glaucoma diagnosis through visualizing blood flow. The optic nerve contains 1.2 million nerve fibers and is indirectly vascularized by the ophthalmic branch of the internal carotid artery. The optic nerve is 45-50 mm in length, including 1 mm intraocular, 25 mm intraorbital, 9 mm intra-canalicular, and 10-15 mm intracranial. In each of these paths, the vascularization is different<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup><sup id="cite_ref-34" class="reference"><a href="#cite_note-34">&#91;34&#93;</a></sup><sup id="cite_ref-35" class="reference"><a href="#cite_note-35">&#91;35&#93;</a></sup>. Consequently, the <b>intracranial</b> optic nerve is supplied by the internal carotid artery, anterior cerebral and anterior communicating arteries. Pial branches from the ophthalmic artery and superior hypophyseal arteries<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup> vascularize the <b>intra-canalicular</b> part. The ophthalmic artery and meningeal anastomoses perfuse the <b>orbital</b> region. The <b>intraocular</b> part further divides into four segments: retrolaminar, lamina cribrosa, prelaminar, and surface nerve fiber layer. Figure 1 shows the vascularization of the optic nerve. Pial arteries and sometimes an axial branch from the central retinal artery supply the <i>retrolaminar</i> part. Blood supply to the <i>lamina cribrosa</i> arises from short posterior ciliary arteries or by the circle of Zinn-Haller, in the sub-scleral space, when it exists. Anastomoses form the Zinn-Haller circle<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup><sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup> from choroidal, pial, and perineural arteries and 4-8 posterior ciliary arteries. Peripapillary and choroid branches from posterior ciliary arteries vascularize the <i>prelaminar</i> region. Arterioles from the central retinal artery perfuse the <i>surface nerve fiber layer</i> of the optic disc.  
</p><p>All parts of the eye drain to the <b>central retinal vein</b>, which drains either into the cavernous sinus or the superior ophthalmic vein.
</p>
<h1><span id="OCT,_OCTA_and_glaucoma"></span><span class="mw-headline" id="OCT.2C_OCTA_and_glaucoma">OCT, OCTA and glaucoma</span></h1>
<p>Glaucomatous neuropathy can be assessed structurally using optical coherence tomography (OCT). OCT devices measure the thickness of several parameters associated with glaucoma, ranging from ganglion cells, retinal nerve fibers layer to the neuro-retinal rim <sup id="cite_ref-:7_39-0" class="reference"><a href="#cite_note-:7-39">&#91;39&#93;</a></sup>. The high resolution and reproducibility of this technology have been suggested to help in diagnosis and progression<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;40&#93;</a></sup><sup id="cite_ref-41" class="reference"><a href="#cite_note-41">&#91;41&#93;</a></sup>. However, assessing a neurodegenerative disease by using neurons' thickness as a primary outcome is sub-optimal. Moreover, specificity and sensitivity vary significantly according to the glaucoma stage. Indeed, OCT can show differences in thickness before visual field changes in glaucoma (more valuable in mild glaucoma) while having a floor effect in more advanced stages of the disease (less helpful)<sup id="cite_ref-:7_39-1" class="reference"><a href="#cite_note-:7-39">&#91;39&#93;</a></sup>. 
</p><p>Technology has therefore evolved further to capture a more dynamic component into these measurements. One example is retinal blood flow, which can provide additional information on the metabolic activity of these retinal cells and hopefully detect changes associated with disease before structural changes. Devices able to provide such information are called OCTA.
</p>
<h2><span class="mw-headline" id="Historical_considerations_and_functioning_principles_of_OCT_and_OCTA">Historical considerations and functioning principles of OCT and OCTA</span></h2>
<p>OCT is an imaging technique based on low-coherence interferometry, to scan tissues cross-sectionally, almost like a microscope. OCT bases on an analogous principle to ultrasound, but it measures the echo time delay and magnitude of light rather than sound, allowing better image resolution. Ultrasonography uses sound waves transmitted into the sample to perform the A-scan; the lag of waves reflected to the transductor determines the depth of the structures. Due to the high speed of the light in OCT, the lag time cannot be measured; hence indirect light assessment was developed: low coherence interferometry. The light reflected by the sample correlates with light that has traveled a known reference path with a translating mirror. Optical interference between both beams of light is demodulated to produce an assessment of ocular structures<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">&#91;42&#93;</a></sup>. 
</p><p>Fercher <i>et al</i>. presented low coherence interferometry for measurements of ocular structures <sup id="cite_ref-43" class="reference"><a href="#cite_note-43">&#91;43&#93;</a></sup>. In the early 90s, Fujimoto <i>et al</i>. further developed OCT in the Massachusetts Institute of Technology<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">&#91;44&#93;</a></sup>. The first OCT was introduced to the ophthalmologic market in 1996 by Zeiss and used time-domain technology (TD-OCT). Moving the reference mirror allowed the detection of different depths in ophthalmic tissue and the establishment of an A-scan, but this moving mirror limited the scanning speed.  
</p><p>In 2002, spectral domain-OCT was developed. Based on a Fourier-transformation of the detected frequencies, this technic improved the signal analysis, noise, and sensitivity, compared with TD-OCT<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">&#91;45&#93;</a></sup>. The imaging speed was increased, without compromising the signal quality, thanks to the absence of reference mirror movement. TD-OCT and the firsts SD-OCT used a wavelength of ≈800 nm. In 2005, a TD-OCT of 1040 nm enhanced choroid penetration. Then, Swept-source OCT (SS-OCT) was developed<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">&#91;46&#93;</a></sup>. TD-OCT was too slow to assess retinal vasculature, but SD-OCT and SS-OCT revived this interest. For more information regarding OCT, visit the respective <a href="/Optical_Coherence_Tomography" title="Optical Coherence Tomography">eyewiki page</a>.
</p><p>OCT-Angiography (OCTA) measured the reflection changes caused by moving particles (erythrocytes) flowing through vessels. Repeatedly capturing OCTs at the same retinal acquisition plane allowed the establishment of image contrast between the perfused vessels and the surrounding unmoving tissues <sup id="cite_ref-:8_47-0" class="reference"><a href="#cite_note-:8-47">&#91;47&#93;</a></sup>. OCTA, which enabled fast, non-invasive, high-resolution imaging of <i>in vivo</i> retinal and choroidal vasculature, was born. In 2015, the first OCTA was commercialized. Since then, several OCTA algorithms were proposed for OCTA image reconstruction and vessel density (VD) quantification.
</p>
<h2><span class="mw-headline" id="Algorithms_and_devices">Algorithms and devices</span></h2>
<p>Commercial OCTA devices use different algorithms (ways of approaching the same technology). The first were the split-spectrum amplitude-decorrelation angiography (SAADA)<sup id="cite_ref-:8_47-1" class="reference"><a href="#cite_note-:8-47">&#91;47&#93;</a></sup><sup id="cite_ref-48" class="reference"><a href="#cite_note-48">&#91;48&#93;</a></sup> by the AngioVue® device (Optovue®), and the OCT-based microangiography (OMAG) by Angioplex® (Zeiss®) <sup id="cite_ref-49" class="reference"><a href="#cite_note-49">&#91;49&#93;</a></sup>. Meanwhile, other algorithms or techniques have been developed, such as the OCTA ratio analysis (OCTARA) in the swept-source OCTA by TopCon®. Different algorithms include a combined intensity and phase-decorrelation method used by AngioScan® (NIDEK®), intensity-decorrelation in SPECTRALIS® (Heidelberg Engineering®) and Canon®, which introduced the Angio Xephilio®. TopCon®(Triton™ DRI), Canon® (Angio Xephilio®) and Zeiss® (PLEX® Elite) provide swept-source OCTA solutions, thus providing higher speed and resolution and increased quality when studying the choroidal layers.  
</p><p>All of these devices lead to slightly different images and metrics <sup id="cite_ref-50" class="reference"><a href="#cite_note-50">&#91;50&#93;</a></sup>. Moreover, several of them have different depths to define each studied layer by default. As a result, direct comparisons are not equivalent across devices for the same patient. 
</p>
<div class="thumb tright"><div class="thumbinner" style="width:612px;"><a href="/File:Fig_2_anamiguel_octa_terminology.png" class="image"><img alt="" src="/w/images/1/thumb/6/60/Fig_2_anamiguel_octa_terminology.png/610px-Fig_2_anamiguel_octa_terminology.png" decoding="async" width="610" height="377" class="thumbimage" srcset="/w/images/1/thumb/6/60/Fig_2_anamiguel_octa_terminology.png/915px-Fig_2_anamiguel_octa_terminology.png 1.5x, /w/images/1/thumb/6/60/Fig_2_anamiguel_octa_terminology.png/1220px-Fig_2_anamiguel_octa_terminology.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_2_anamiguel_octa_terminology.png" class="internal" title="Enlarge"></a></div>Figure 2. OCTA terminology</div></div></div>
<h2><span class="mw-headline" id="Terminology_in_OCTA">Terminology in OCTA</span></h2>
<p>For coherence, we present OCTA-related definitions <sup id="cite_ref-:6_5-1" class="reference"><a href="#cite_note-:6-5">&#91;5&#93;</a></sup> (figure 2): 
</p><p>· &#160; &#160; &#160;Vessel density (VD): the percentage of area occupied by vessels, pictured by lighter tones of grey
</p><p>· &#160; &#160; &#160;Whole-image VD: the VD detected in the entire scan (whole-image optic disc, whole-image macular scan, etc.)
</p><p>· &#160; &#160; &#160;Peripapillary VD: the VD within a 750-µm-wide annulus extending from the optic disc boundary.
</p><p>· &#160; &#160; &#160;Parafoveal VD: the VD between two circles centered in the fovea with diameters of 1 mm and 3 mm
</p><p>· &#160; &#160; &#160;Perifoveal VD: the VD within diameters of 3 mm and 5 mm. 
</p>
<h2><span class="mw-headline" id="Technique_description">Technique description</span></h2><p>
As an example of performing OCTA in glaucoma, we used Triton (Topcon®, Japan), after pupillary dilatation if the pupil was smaller than 4 mm, with a scan size of 4.5 x 4.5 mm, centered on the optic disc. Triton provides a grayscale for each slab and a color image with the combination of all slabs <sup id="cite_ref-:6_5-2" class="reference"><a href="#cite_note-:6-5">&#91;5&#93;</a></sup> (figures in clinical cases below). This device presents a qualitative impression of vessel density (VD). We should exclude low-quality images with signal strength index (SSI) less than 40 (or 6 in Zeiss), motion artifacts, vessel segmentation, or media opacities. Video 1 shows one example of OCTA acquisition. Below (in clinical cases), we present several images as examples of OCTA.  </p><div class="thumb tright"><div class="thumbinner" style="width:559px;"><a href="/File:Fig_3_anamiguel_octa_healthy.png" class="image"><img alt="" src="/w/images/1/thumb/8/85/Fig_3_anamiguel_octa_healthy.png/557px-Fig_3_anamiguel_octa_healthy.png" decoding="async" width="557" height="302" class="thumbimage" srcset="/w/images/1/thumb/8/85/Fig_3_anamiguel_octa_healthy.png/836px-Fig_3_anamiguel_octa_healthy.png 1.5x, /w/images/1/thumb/8/85/Fig_3_anamiguel_octa_healthy.png/1114px-Fig_3_anamiguel_octa_healthy.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_3_anamiguel_octa_healthy.png" class="internal" title="Enlarge"></a></div>Figure 3. OCTA of a healthy person, centered in the optic disc.</div></div></div>
<p><br />
</p>
<p><iframe width="560" height="315" src="//www.youtube-nocookie.com/embed/ORyECfMI4w8" frameborder="0" allowfullscreen=""></iframe></p><div class="thumb tright"><div class="thumbinner" style="width:554px;"><a href="/File:Fig_4_anamiguel_octa_glaucoma.png" class="image"><img alt="" src="/w/images/1/thumb/6/66/Fig_4_anamiguel_octa_glaucoma.png/552px-Fig_4_anamiguel_octa_glaucoma.png" decoding="async" width="552" height="308" class="thumbimage" srcset="/w/images/1/thumb/6/66/Fig_4_anamiguel_octa_glaucoma.png/828px-Fig_4_anamiguel_octa_glaucoma.png 1.5x, /w/images/1/thumb/6/66/Fig_4_anamiguel_octa_glaucoma.png/1104px-Fig_4_anamiguel_octa_glaucoma.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_4_anamiguel_octa_glaucoma.png" class="internal" title="Enlarge"></a></div>Figure 4. OCTA of a glaucomatous patient (darker greys and bluer color are appreciated compared to a healthy subject).</div></div></div>
<h2><span class="mw-headline" id="OCTA_and_diagnostics_of_glaucoma">OCTA and diagnostics of glaucoma</span></h2>
<p>OCTA helps in the diagnosis of glaucoma, providing both functional and structural information <sup id="cite_ref-:6_5-3" class="reference"><a href="#cite_note-:6-5">&#91;5&#93;</a></sup>. Our recent meta-analysis concluded that vessel density (VD) is lower in glaucoma eyes compared with controls in all macular and peripapillary regions assessed <sup id="cite_ref-:6_5-4" class="reference"><a href="#cite_note-:6-5">&#91;5&#93;</a></sup>, as appreciated in figures 3 and 4. It seems that reduction in perfusion is more pronounced in superficial layers, both in the peripapillary <sup id="cite_ref-51" class="reference"><a href="#cite_note-51">&#91;51&#93;</a></sup> and macular <sup id="cite_ref-:9_52-0" class="reference"><a href="#cite_note-:9-52">&#91;52&#93;</a></sup> regions. This VD decrease was more pronounced in advanced glaucoma than moderate-mild glaucoma <sup id="cite_ref-:9_52-1" class="reference"><a href="#cite_note-:9-52">&#91;52&#93;</a></sup><sup id="cite_ref-:10_53-0" class="reference"><a href="#cite_note-:10-53">&#91;53&#93;</a></sup><sup id="cite_ref-54" class="reference"><a href="#cite_note-54">&#91;54&#93;</a></sup><sup id="cite_ref-55" class="reference"><a href="#cite_note-55">&#91;55&#93;</a></sup><sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup>.  
</p><p>Microvascular dropout (MvD) is the choriocapillaris loss in regions of parapapillary atrophy <sup id="cite_ref-:11_57-0" class="reference"><a href="#cite_note-:11-57">&#91;57&#93;</a></sup><sup id="cite_ref-58" class="reference"><a href="#cite_note-58">&#91;58&#93;</a></sup>, often inferotemporally within ß-zone<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">&#91;59&#93;</a></sup> .&#160; MvD was associated with structural (RNFL thinning and lamina cribrosa defects) and functional (VF loss) defects<sup id="cite_ref-:11_57-1" class="reference"><a href="#cite_note-:11-57">&#91;57&#93;</a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60">&#91;60&#93;</a></sup> and disc hemorrhages <sup id="cite_ref-61" class="reference"><a href="#cite_note-61">&#91;61&#93;</a></sup>. Similar to VD, the prevalence and size of MvD increase with glaucoma severity <sup id="cite_ref-:11_57-2" class="reference"><a href="#cite_note-:11-57">&#91;57&#93;</a></sup><sup id="cite_ref-62" class="reference"><a href="#cite_note-62">&#91;62&#93;</a></sup>. MvD also seemed to predict a faster rate of RNFL thinning and VF loss <sup id="cite_ref-63" class="reference"><a href="#cite_note-63">&#91;63&#93;</a></sup>. 
</p><p>The diagnostic performance of OCTA was compared with OCT, namely with RNFL thickness and GCC thickness, was similar <sup id="cite_ref-:10_53-1" class="reference"><a href="#cite_note-:10-53">&#91;53&#93;</a></sup><sup id="cite_ref-64" class="reference"><a href="#cite_note-64">&#91;64&#93;</a></sup><sup id="cite_ref-:15_65-0" class="reference"><a href="#cite_note-:15-65">&#91;65&#93;</a></sup>. However, some studies reported a better sensitivity of RNFL (OCT) in early glaucoma <sup id="cite_ref-66" class="reference"><a href="#cite_note-66">&#91;66&#93;</a></sup>. Several other studies reported a better correlation between visual field (VF) and VD than between VF and OCT <sup id="cite_ref-:6_5-5" class="reference"><a href="#cite_note-:6-5">&#91;5&#93;</a></sup>, being this correlation stronger in eyes with high myopia <sup id="cite_ref-67" class="reference"><a href="#cite_note-67">&#91;67&#93;</a></sup> and advanced glaucoma <sup id="cite_ref-68" class="reference"><a href="#cite_note-68">&#91;68&#93;</a></sup>.  
</p>
<h2><span class="mw-headline" id="OCTA_and_longitudinal_studies">OCTA and longitudinal studies</span></h2>
<p>The majority of longitudinal OCTA studies in glaucoma with at least three months of follow-up found an association between OCTA changes and structural (OCT) and functional (VF) decline <sup id="cite_ref-69" class="reference"><a href="#cite_note-69">&#91;69&#93;</a></sup>.&#160; VD decline correlated with baseline values <sup id="cite_ref-:16_70-0" class="reference"><a href="#cite_note-:16-70">&#91;70&#93;</a></sup><sup id="cite_ref-:12_71-0" class="reference"><a href="#cite_note-:12-71">&#91;71&#93;</a></sup>, the difference between control and glaucoma<sup id="cite_ref-72" class="reference"><a href="#cite_note-72">&#91;72&#93;</a></sup>, and progression measured by OCT <sup id="cite_ref-:13_73-0" class="reference"><a href="#cite_note-:13-73">&#91;73&#93;</a></sup> and VF <sup id="cite_ref-:12_71-1" class="reference"><a href="#cite_note-:12-71">&#91;71&#93;</a></sup>. A faster loss of macular VD (OCTA) in POAG&#160; than glaucoma-suspect or healthy eyes was observed, but not significantly in GCC (OCT)<sup id="cite_ref-:13_73-1" class="reference"><a href="#cite_note-:13-73">&#91;73&#93;</a></sup>. Software-assisted removal of large vessels <sup id="cite_ref-:14_74-0" class="reference"><a href="#cite_note-:14-74">&#91;74&#93;</a></sup> better allowed to identify VD decline. 
</p><p>Despite the lack of long-term follow-up studies to ascertain the role of OCTA in glaucoma progression, some studies demonstrated its ability to detect disease progression in superficial VD <sup id="cite_ref-:14_74-1" class="reference"><a href="#cite_note-:14-74">&#91;74&#93;</a></sup>. Moreover, lower baseline peripapillary and macular VD were associated with a faster rate of RNFL progression in mild to moderate glaucoma in a study with a mean follow-up over two years <sup id="cite_ref-75" class="reference"><a href="#cite_note-75">&#91;75&#93;</a></sup>.&#160; This association was independent of the baseline RNFL thickness, suggesting that OCTA may offer an additional contribution to assess glaucoma risk of progression <sup id="cite_ref-:15_65-1" class="reference"><a href="#cite_note-:15-65">&#91;65&#93;</a></sup>. However, VD is more sensitive than RNFL to IOP changes and variations in systemic perfusion and retinal oxygenation<sup id="cite_ref-:15_65-2" class="reference"><a href="#cite_note-:15-65">&#91;65&#93;</a></sup>. 
</p><p>The current limitation to fully assess OCTA in glaucoma is the lack of standardization in protocol and devices and the scarcity of long-term longitudinal studies. Nevertheless, it was possible to detect a decrease in VD through glaucoma progression, according to a recent systematic review<sup id="cite_ref-:16_70-1" class="reference"><a href="#cite_note-:16-70">&#91;70&#93;</a></sup>. It was possible to show decreased VD with glaucoma aggravation, but is it possible to see VD improvement after surgery?
</p>
<h2><span class="mw-headline" id="OCTA_and_glaucoma_surgery">OCTA and glaucoma surgery</span></h2>
<p>Currently, a few studies have evaluated the VD response to glaucoma surgery using OCTA <sup id="cite_ref-:17_76-0" class="reference"><a href="#cite_note-:17-76">&#91;76&#93;</a></sup><sup id="cite_ref-:13_73-2" class="reference"><a href="#cite_note-:13-73">&#91;73&#93;</a></sup><sup id="cite_ref-77" class="reference"><a href="#cite_note-77">&#91;77&#93;</a></sup><sup id="cite_ref-:18_78-0" class="reference"><a href="#cite_note-:18-78">&#91;78&#93;</a></sup>. Surgically-induced IOP-lowering causes changes in ocular hemodynamics<sup id="cite_ref-79" class="reference"><a href="#cite_note-79">&#91;79&#93;</a></sup>, specifically an increase in ocular blood flow <sup id="cite_ref-80" class="reference"><a href="#cite_note-80">&#91;80&#93;</a></sup><sup id="cite_ref-81" class="reference"><a href="#cite_note-81">&#91;81&#93;</a></sup>. A significant increase in microvascular VD was noted after glaucoma surgery in several studies <sup id="cite_ref-:17_76-1" class="reference"><a href="#cite_note-:17-76">&#91;76&#93;</a></sup><sup id="cite_ref-82" class="reference"><a href="#cite_note-82">&#91;82&#93;</a></sup><sup id="cite_ref-83" class="reference"><a href="#cite_note-83">&#91;83&#93;</a></sup> (except one<sup id="cite_ref-:13_73-3" class="reference"><a href="#cite_note-:13-73">&#91;73&#93;</a></sup>). VD increase correlated with higher preoperative IOP, more significant IOP reduction, and reduced lamina cribrosa depth. The microvascular response seemed different between retinal territories. In particular, a study<sup id="cite_ref-:18_78-1" class="reference"><a href="#cite_note-:18-78">&#91;78&#93;</a></sup> showed that peripapillary VD was IOP-independent within the studied range of surgically controlled IOP, while macular VD revealed a delayed response followed by near-normal reperfusion after glaucoma surgery. OCTA may play a promising role in evaluating vascular recovery post-glaucoma surgery.  
</p><p>
However, the available studies present limitations, including a short follow-up period (ranging from 3-months to 1-year)<sup id="cite_ref-:16_70-2" class="reference"><a href="#cite_note-:16-70">&#91;70&#93;</a></sup>. Also, few studies recorded the number of topical anti-glaucoma medications in the postoperative period, except for one study<sup id="cite_ref-:18_78-2" class="reference"><a href="#cite_note-:18-78">&#91;78&#93;</a></sup>, the remainder evaluated only trabeculectomy. Nevertheless, it seems VD changes after glaucoma surgery, and OCTA could evaluate vascular recovery.</p><div class="thumb tright"><div class="thumbinner" style="width:641px;"><a href="https://eyewiki.org/File:Fig_9.3_anamiguel_iris_iritis.png"><img alt="" src="/w/images/1/thumb/c/c9/Fig_9.3_anamiguel_iris_iritis.png/639px-Fig_9.3_anamiguel_iris_iritis.png" decoding="async" width="639" height="308" class="thumbimage" srcset="/w/images/1/thumb/c/c9/Fig_9.3_anamiguel_iris_iritis.png/959px-Fig_9.3_anamiguel_iris_iritis.png 1.5x, /w/images/1/thumb/c/c9/Fig_9.3_anamiguel_iris_iritis.png/1278px-Fig_9.3_anamiguel_iris_iritis.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_9.3_anamiguel_iris_iritis.png" class="internal" title="Enlarge"></a></div>Figure 5. OCTA of iris versus iritis. On the left side of the figure, we present the normal iris vascularization. On the right side, iritis is visible, showing vessel dilation and irregularity.</div></div></div>
<h2><span class="mw-headline" id="OCTA_of_the_anterior_segment">OCTA of the anterior segment</span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:402px;"><a href="https://eyewiki.org/File:Fig_7.3_anamiguel_octa_bleb.png"><img alt="" src="/w/images/1/thumb/4/4e/Fig_7.3_anamiguel_octa_bleb.png/400px-Fig_7.3_anamiguel_octa_bleb.png" decoding="async" width="400" height="326" class="thumbimage" srcset="/w/images/1/thumb/4/4e/Fig_7.3_anamiguel_octa_bleb.png/600px-Fig_7.3_anamiguel_octa_bleb.png 1.5x, /w/images/1/thumb/4/4e/Fig_7.3_anamiguel_octa_bleb.png/800px-Fig_7.3_anamiguel_octa_bleb.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_7.3_anamiguel_octa_bleb.png" class="internal" title="Enlarge"></a></div>Figure 6. OCTA of the anterior segment showing an avascular filtration bleb.</div></div></div><p>We have mentioned OCTA utilization in assessing papillary and retinal vascularization, but OCTA of the anterior segment can also be of value, namely for evaluating the filtration bleb.  
</p><p>Trabeculectomy is the most common glaucoma surgery<sup id="cite_ref-:0_1-2" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Nonetheless, fibrosis (scar formation) is the primary cause of failure of glaucoma surgeries <sup id="cite_ref-84" class="reference"><a href="#cite_note-84">&#91;84&#93;</a></sup>. Angiogenesis is essential for the wound-healing process, and inflammation promotes bleb vascularization and fibrosis <sup id="cite_ref-85" class="reference"><a href="#cite_note-85">&#91;85&#93;</a></sup>. Thus, a meticulous clinical follow-up of the filtering bleb is necessary, and an avascular bleb is predictive of a functioning bleb. There are slit-lamp bleb evaluation scales, namely Indiana Bleb Appearance Grading Scale <sup id="cite_ref-86" class="reference"><a href="#cite_note-86">&#91;86&#93;</a></sup> or Moorfields Bleb Grading Scale<sup id="cite_ref-87" class="reference"><a href="#cite_note-87">&#91;87&#93;</a></sup> . Both scales focus on the vascularity of the bleb, but this clinical evaluation remains subjective and not reproductive. 
</p><p>OCTA of the anterior segment was used to evaluate corneal, iris, and conjunctival vessels <sup id="cite_ref-88" class="reference"><a href="#cite_note-88">&#91;88&#93;</a></sup> and for filtering bleb evaluation.&#160; Figure 5 depicts the difference between normal iris and iritis distinguished by OCTA. Yin <i>et al.</i> found a peak in bleb vessel density (VD) one month after trabeculectomy using OCTA, identifying a correlation between the vessel area one month post-trabeculectomy and IOP six months post-surgery<sup id="cite_ref-89" class="reference"><a href="#cite_note-89">&#91;89&#93;</a></sup>. OCTA color and brightness density of the bleb-wall correlated with the clinical bleb scales in 92 patients who underwent trabeculectomy<sup id="cite_ref-90" class="reference"><a href="#cite_note-90">&#91;90&#93;</a></sup>. Hayek et al.<sup id="cite_ref-:19_91-0" class="reference"><a href="#cite_note-:19-91">&#91;91&#93;</a></sup> studied the conjunctiva before and after trabeculectomy and concluded that preoperative VD is a good indicator of surgical success. Poor conjunctival vascularization was associated with lower IOP and more intraepithelial microcysts on OCTA at six months of follow-up<sup id="cite_ref-:19_91-1" class="reference"><a href="#cite_note-:19-91">&#91;91&#93;</a></sup>. 
</p><p>As for micro-invasive glaucoma surgeries (MIGS), filtration bleb after XEN surgery was evaluated with OCTA<sup id="cite_ref-92" class="reference"><a href="#cite_note-92">&#91;92&#93;</a></sup>. Successful filtration bleb after XEN gel implantation presented numerous and large areas of vessel displacement with the bleb-wall, along with a rarefied vascular network. Postoperative intraocular pressure correlated with low bleb-wall VD. 
</p><p>In conclusion, OCTA seems to gain a prominent role in postoperative bleb assessment. An avascular bleb is ideal, such as the one observed in figure 6. An OCTA classification could help clinicians in patient management. 
</p>
<h2><span class="mw-headline" id="OCTA_and_systemic_and_neuro-ophthalmological_diseases">OCTA and systemic and neuro-ophthalmological diseases</span></h2>
<p>The possibility of direct viewing and quantifying ocular blood flow with OCTA gained the attention of several fields other than glaucoma and even outside ophthalmology. 
</p>
<h3><span class="mw-headline" id="OCTA_and_systemic_pathologies">OCTA and systemic pathologies</span></h3>
<p>The application of this technology in disease detection and monitoring in cardiovascular diseases is flourishing. Microvascular vessel density (VD) decrease was found in hypertension, kidney disease, preeclampsia, coronary artery disease, and carotid artery stenosis <sup id="cite_ref-93" class="reference"><a href="#cite_note-93">&#91;93&#93;</a></sup>.&#160; Although vascular changes are a hallmark in diabetic retinopathy, diabetic patients show changes in the retinal vascular plexus in OCTA even before retinopathy <sup id="cite_ref-94" class="reference"><a href="#cite_note-94">&#91;94&#93;</a></sup>.&#160; 
</p><p>Vascular abnormalities were further described in neurological conditions such as multiple sclerosis (MS), Alzheimer's disease, and Parkinson's disease with disease severity association in some studies<sup id="cite_ref-:20_95-0" class="reference"><a href="#cite_note-:20-95">&#91;95&#93;</a></sup>. Autoimmune diseases with vessel dysfunction such as systemic lupus erythematosus and rheumatoid arthritis likewise showed vessel rarefaction on OCTA<sup id="cite_ref-96" class="reference"><a href="#cite_note-96">&#91;96&#93;</a></sup>. Drug toxicity screening might be a novel use for OCTA, as abnormalities in hydroxychloroquine or tamoxifen users without retinopathy were detected<sup id="cite_ref-97" class="reference"><a href="#cite_note-97">&#91;97&#93;</a></sup>. In the wake of the COVID-19 pandemic, OCTA was used to analyze the retinal vasculature of patients with resolved SARS-COV-2 infection<sup id="cite_ref-98" class="reference"><a href="#cite_note-98">&#91;98&#93;</a></sup>.
</p>
<h3><span class="mw-headline" id="Multiple_sclerosis">Multiple sclerosis</span></h3>
<p>Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system leading to demyelination in cerebral regions. Optic neuritis (ON) represents the most common ocular manifestation of MS<sup id="cite_ref-99" class="reference"><a href="#cite_note-99">&#91;99&#93;</a></sup>. The macular vessel density (VD) is significantly reduced in patients with MS comparing to healthy subjects <sup id="cite_ref-:21_100-0" class="reference"><a href="#cite_note-:21-100">&#91;100&#93;</a></sup><sup id="cite_ref-:22_101-0" class="reference"><a href="#cite_note-:22-101">&#91;101&#93;</a></sup> independently of the previous ON (according to some studies<sup id="cite_ref-:22_101-1" class="reference"><a href="#cite_note-:22-101">&#91;101&#93;</a></sup><sup id="cite_ref-:21_100-1" class="reference"><a href="#cite_note-:21-100">&#91;100&#93;</a></sup>, but not all<sup id="cite_ref-102" class="reference"><a href="#cite_note-102">&#91;102&#93;</a></sup>). 
</p><p>The optic nerve head (ONH) flow index was significantly lower for MS with a history of ON, compared to healthy subjects and MS without ON<sup id="cite_ref-103" class="reference"><a href="#cite_note-103">&#91;103&#93;</a></sup>. Similarly, a microvascular peripapillary VD decrease was found in MS. The rarefaction of retinal and optic nerve VD in MS is possibly due to reduced metabolic supply or inflammatory processes<sup id="cite_ref-:20_95-1" class="reference"><a href="#cite_note-:20-95">&#91;95&#93;</a></sup>.
</p>
<h3><span class="mw-headline" id="Anterior_ischemic_optic_neuropathy">Anterior ischemic optic neuropathy</span></h3>
<p>Anterior ischemic optic neuropathy (AION) affects the anterior portion of the optic nerve and divides into non-arteritic (NA-AION) and arteritic (A-AION). The NA-AION is the most common, occurring in middle-aged and elderly patients, and is associated with cardiovascular risk factors. The second often associates with giant cell arteritis. NA-AION might be related to transient hypoperfusion or non-perfusion of the optic nerve head<sup id="cite_ref-104" class="reference"><a href="#cite_note-104">&#91;104&#93;</a></sup>. One study found a macular VD decrease in the contralateral eye of NA-AION <sup id="cite_ref-105" class="reference"><a href="#cite_note-105">&#91;105&#93;</a></sup>, but not another<sup id="cite_ref-:23_106-0" class="reference"><a href="#cite_note-:23-106">&#91;106&#93;</a></sup>. Peripapillary VD correlated with visual field defects<sup id="cite_ref-:24_107-0" class="reference"><a href="#cite_note-:24-107">&#91;107&#93;</a></sup>. 
</p><p>OCTA shows a reduction in peripapillary VD, macular capillary VD, and choroidal VD in the atrophic stage of NA-AION<sup id="cite_ref-:24_107-1" class="reference"><a href="#cite_note-:24-107">&#91;107&#93;</a></sup>. At the acute phase, edema hinders the assessment of the peripapillary plexus; hence, RNFL segmentation allows better visualization due to reduced edema-related darkening <sup id="cite_ref-108" class="reference"><a href="#cite_note-108">&#91;108&#93;</a></sup>. Peripapillary VD was lower for patients with NA-AION than in the fellow eye and the affected eye of patients with other diseases<sup id="cite_ref-109" class="reference"><a href="#cite_note-109">&#91;109&#93;</a></sup>. OCTA cannot differentiate the two types of AION. Nevertheless, there seems to be a significantly worse optic nerve hypoperfusion for A-AION compared to NA-AION<sup id="cite_ref-:23_106-1" class="reference"><a href="#cite_note-:23-106">&#91;106&#93;</a></sup>.
</p>
<h3><span class="mw-headline" id="Leber_hereditary_optic_neuropathy">Leber hereditary optic neuropathy</span></h3>
<p>Leber hereditary optic neuropathy is a rare genetic disorder inherited by the maternal mitochondrial DNA, affecting young males. At the acute stage, tortuosity and swelling of the peripapillary capillaries were described<sup id="cite_ref-110" class="reference"><a href="#cite_note-110">&#91;110&#93;</a></sup>. OCTA studies showed a gradual reduction of peripapillary capillary VD, beginning temporally <sup id="cite_ref-111" class="reference"><a href="#cite_note-111">&#91;111&#93;</a></sup> even before RNFL thinning. Parafoveal VD was also decreased, mainly in nasal and inferior regions, reflecting damage of the papillomacular bundle<sup id="cite_ref-112" class="reference"><a href="#cite_note-112">&#91;112&#93;</a></sup>.
</p>
<h3><span class="mw-headline" id="Dominant_optic_atrophy">Dominant optic atrophy</span></h3>
<p>Dominant optic atrophy is a mitochondrial inherited optic neuropathy affecting children. It is characterized by bilateral degeneration of retinal ganglion cells and their axons with optic disc atrophy and pallor, causing insidious visual loss. Most cases are associated with mutations in the OPA1 gene, with incomplete penetrance and variable expression<sup id="cite_ref-113" class="reference"><a href="#cite_note-113">&#91;113&#93;</a></sup>.
</p><p>OCTA shows a diffuse decrease of peripapillary and parafoveal VD. VD reduction correlates with RNFL and GCC thickening and visual field loss<sup id="cite_ref-114" class="reference"><a href="#cite_note-114">&#91;114&#93;</a></sup>.
</p>
<h3><span class="mw-headline" id="Optic_disc_swelling">Optic disc swelling</span></h3>
<p>Bilateral optic disc edema is often related to papilledema and requires magnetic resonance imaging of the brain. Fluorescein angiography can help diagnose AION if there is perfusion delay or hypoperfusion of the optic nerve head. Otherwise, diffuse dye leakage hides optic microvasculature.
</p><p>A study assessed peripapillary vascular changes in acute optic disc swelling due to different etiologies<sup id="cite_ref-115" class="reference"><a href="#cite_note-115">&#91;115&#93;</a></sup>. The peripapillary VD was significantly lower in NA-AION than papilledema. However, the distinction between other diseases was less clear (optic neuritis, papilledema, and A-AION). Peripapillary VD tended to decrease in idiopathic intracranial hypertension (IIC) compared to healthy subjects, but not in regressed papilledema<sup id="cite_ref-116" class="reference"><a href="#cite_note-116">&#91;116&#93;</a></sup>. Another study identified no difference in IIC after excluding the large vessels<sup id="cite_ref-:25_117-0" class="reference"><a href="#cite_note-:25-117">&#91;117&#93;</a></sup>. Further research is required to clarify the vascular changes in patients with acute optic disc swelling.
</p><p>OCTA was also studied to distinguish <b>papilledema from pseudopapilledema</b><sup id="cite_ref-:25_117-1" class="reference"><a href="#cite_note-:25-117">&#91;117&#93;</a></sup>. This can be exciting due to the underlying condition of papilledema that can threaten the life's patient. Whole and nasal peripapillary capillary VD were reduced for pseudopapilledema compared to papilledema. This difference was not statistically significant in severe papilledema but was in low-grade papilledema. OCTA could be promising to help differentiate mild papilledema from pseudopapilledema.
</p>
<h3><span class="mw-headline" id="Optic_disc_drusen">Optic disc drusen</span></h3>
<p>Optic disc drusen (ODD) are acellular deposits within the optic nerve head, well diagnosed by autofluorescence, echography, and enhanced depth-OCT<sup id="cite_ref-:26_118-0" class="reference"><a href="#cite_note-:26-118">&#91;118&#93;</a></sup>. These deposits are often bilateral and lead to progressive visual field loss due to degenerative optic neuropathy<sup id="cite_ref-:26_118-1" class="reference"><a href="#cite_note-:26-118">&#91;118&#93;</a></sup>. Mechanical compression of retinal nerve fibers by drusen in the optic disc or vascular theory are potential explanations.
</p><p>Peripapillary microvascular density is reduced in ODD compared to healthy subjects<sup id="cite_ref-:27_119-0" class="reference"><a href="#cite_note-:27-119">&#91;119&#93;</a></sup>. Low peripapillary VD was associated with visual field loss<sup id="cite_ref-120" class="reference"><a href="#cite_note-120">&#91;120&#93;</a></sup>. One study of macular microvasculature supply found no difference between ODD and healthy subjects<sup id="cite_ref-:27_119-1" class="reference"><a href="#cite_note-:27-119">&#91;119&#93;</a></sup>. Moreover, macular vessel diameter and flux increased in patients with ODD and visual field loss, without changes in RNFL, GCC, and peripapillary VD. Increased macular vessel diameter could be an early marker for visual field loss.
</p>
<h3><span class="mw-headline" id="Compressive_optic_neuropathy">Compressive optic neuropathy</span></h3>
<p>Compressive optic neuropathy results from mechanical compression secondary to a tumor or benign lesions. The compression can occur in the anterior visual pathway (optic nerve) or posteriorly. 
</p><p>A study of optic pathway gliomas identified a decrease in RNFL and GCC thickness (OCT) and in peripapillary VD (OCTA). Macular VD was decreased compared to healthy subjects, but not optic disc VD<sup id="cite_ref-121" class="reference"><a href="#cite_note-121">&#91;121&#93;</a></sup>. Studies of chiasmatic compressive optic neuropathy linked to pituitary adenomas found reduced peripapillary VD and superficial capillary (SCP) perfusion, but normal deep capillary perfusion compared to healthy eyes<sup id="cite_ref-122" class="reference"><a href="#cite_note-122">&#91;122&#93;</a></sup>. Peripapillary VD loss affected temporal and nasal sectors, with sparing of superior and inferior areas, which is consistent with several studies relating severe temporal RNFL thinning<sup id="cite_ref-123" class="reference"><a href="#cite_note-123">&#91;123&#93;</a></sup><sup id="cite_ref-124" class="reference"><a href="#cite_note-124">&#91;124&#93;</a></sup>. VD loss was associated with OCT and visual field defects. In a unilateral postgeniculate visual pathway lesion, a similar pattern distribution for GCC thinning (OCT) and reduction of macular superficial density and peripapillary VD (OCTA)were observed<sup id="cite_ref-125" class="reference"><a href="#cite_note-125">&#91;125&#93;</a></sup>.
</p>
<h3><span class="mw-headline" id="Radiation_optic_neuropathy">Radiation optic neuropathy</span></h3>
<p>Radiation retinopathy and radiation optic neuropathy are complications of radiation treatment. In eyes treated with brachytherapy for uveal melanoma and with radiation retinopathy or optic neuropathy, the decrease of peripapillary VD correlated with the radiation dose to the optic disc and the visual acuity<sup id="cite_ref-126" class="reference"><a href="#cite_note-126">&#91;126&#93;</a></sup>. Recently, a prospective study confirmed peripapillary and macular ischemia induced by brachytherapy, and a grading system based on OCTA VD was proposed<sup id="cite_ref-127" class="reference"><a href="#cite_note-127">&#91;127&#93;</a></sup>.
</p>
<h1><span class="mw-headline" id="Clinical_cases_and_images_of_OCTA_and_glaucoma">Clinical cases and images of OCTA and glaucoma</span></h1>
<div class="thumb tright"><div class="thumbinner" style="width:470px;"><a href="/File:Fig_5_anamiguel_octa_macular.png" class="image"><img alt="" src="/w/images/1/thumb/9/92/Fig_5_anamiguel_octa_macular.png/468px-Fig_5_anamiguel_octa_macular.png" decoding="async" width="468" height="548" class="thumbimage" srcset="/w/images/1/thumb/9/92/Fig_5_anamiguel_octa_macular.png/701px-Fig_5_anamiguel_octa_macular.png 1.5x, /w/images/1/thumb/9/92/Fig_5_anamiguel_octa_macular.png/935px-Fig_5_anamiguel_octa_macular.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_5_anamiguel_octa_macular.png" class="internal" title="Enlarge"></a></div>Figure 7. Macular OCTA of healthy versus glaucomatous patient.</div></div></div>
<p>We present some examples of OCTA application in clinical practice. 
</p>
<h2><span class="mw-headline" id="Healthy_patient_-_optic_nerve_OCTA">Healthy patient - optic nerve OCTA</span></h2>
<p>Figure 3 (above) shows the OCTA scan of the optic nerve of a healthy patient with Triton device. Triton scans the optic disc using a long-wavelength scanning light of 1050nm at a speed of 100000 A-scans per second. This device analyses different retinal slabs (or retinal depths): optic nerve, radial peripapillary capillary (RPC), vitreous, choroid, as seen in the figure. It provides a grayscale for each slab and a color image (density map) with the combination of all slabs. It also shows an eye fundus image and OCT B-scan. At the moment, this device presents only qualitative VD for the optic disc. This healthy subject has light grays in all slabs and a predominance of red colors, showing high VD.    
</p>
<h2><span class="mw-headline" id="Glaucomatous_patient_-_whole-image_optic_nerve_OCTA">Glaucomatous patient - whole-image optic nerve OCTA</span></h2>
<p>Figure 4 (above) shows the OCTA of a glaucomatous patient with Triton. We can appreciate darker gray shadows in each slab. A whole-image optic nerve VD decrease is visible in the density map, illustrated by darker and bluer colors, more pronounced in the inferior hemifield.                                    
</p>
<h2><span id="Glaucomatous_versus_healthy_patient_–_whole-image_macular_OCTA"></span><span class="mw-headline" id="Glaucomatous_versus_healthy_patient_.E2.80.93_whole-image_macular_OCTA">Glaucomatous <i>versus</i> healthy patient – whole-image macular OCTA</span></h2>
<p>Figure 7 illustrates the whole-image macular OCTA of a glaucomatous patient (above) and compares it to a healthy patient (below). We can appreciate located darker zones in nearly all OCTA slabs (depths) in glaucoma (blue arrows), more evident in the color image. There were minor movement artifacts in the glaucoma OCTA (stars).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
</p>
<div class="thumb tright"><div class="thumbinner" style="width:470px;"><a href="/File:Fig_6_anamiguel_octa_asymmetric_glaucoma.png" class="image"><img alt="" src="/w/images/1/thumb/d/d0/Fig_6_anamiguel_octa_asymmetric_glaucoma.png/468px-Fig_6_anamiguel_octa_asymmetric_glaucoma.png" decoding="async" width="468" height="351" class="thumbimage" srcset="/w/images/1/thumb/d/d0/Fig_6_anamiguel_octa_asymmetric_glaucoma.png/702px-Fig_6_anamiguel_octa_asymmetric_glaucoma.png 1.5x, /w/images/1/thumb/d/d0/Fig_6_anamiguel_octa_asymmetric_glaucoma.png/936px-Fig_6_anamiguel_octa_asymmetric_glaucoma.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_6_anamiguel_octa_asymmetric_glaucoma.png" class="internal" title="Enlarge"></a></div>Figure 8. OCTA of asymmetric glaucoma and respective visual fields.</div></div></div>
<h2><span class="mw-headline" id="Advanced_asymmetric_glaucoma_and_myopia">Advanced asymmetric glaucoma and myopia</span></h2>
<p>We depict a patient with myopia and advanced asymmetric glaucoma. The visual field of the left eye (left-side of figure 8, "OS") is almost lost (mean deviation of -28dB), and the respective whole-image optic nerve OCTA is very dark (the "colour map" is blue, showing an extremely decreased VD). The right visual field shows a less severe but advanced loss, and the right OCTA is less altered. Notice that the OCTA of the right eye has movement artifacts and has an SSI of 48, less than recommended. The peripapillary atrophy shown in the retinography is consistent with myopia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                
</p><p><br />
</p><p><br />
</p><p><br />
</p><p><br />
</p>
<h2><span class="mw-headline" id="OCTA_VD_increase_after_glaucoma_surgery">OCTA VD increase after glaucoma surgery</span></h2>
<p>Figure 9 shows two patients who had laser suture lysis to further decrease IOP during the first month after a trabeculectomy. An OCTA was performed before and 15 minutes after laser suture lysis. This maneuver allowed an IOP decrease and a VD increase in localized regions (red ovals), possibly reflecting vascularization improvement.  
</p>
<div class="thumb tright"><div class="thumbinner" style="width:462px;"><a href="/File:Fig_8.2_anamiguel_octa_improvement.png" class="image"><img alt="" src="/w/images/1/thumb/c/c8/Fig_8.2_anamiguel_octa_improvement.png/460px-Fig_8.2_anamiguel_octa_improvement.png" decoding="async" width="460" height="247" class="thumbimage" srcset="/w/images/1/thumb/c/c8/Fig_8.2_anamiguel_octa_improvement.png/690px-Fig_8.2_anamiguel_octa_improvement.png 1.5x, /w/images/1/thumb/c/c8/Fig_8.2_anamiguel_octa_improvement.png/920px-Fig_8.2_anamiguel_octa_improvement.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_8.2_anamiguel_octa_improvement.png" class="internal" title="Enlarge"></a></div>Figure 9. VD increase after IOP decrease during the postoperative period.</div></div></div>  
<p><br /> 
</p><p><br /> 
</p><p><br />
</p>
<div class="thumb tright"><div class="thumbinner" style="width:649px;"><a href="/File:Fig_10_anamiguel_octa_macula_2_devices.png" class="image"><img alt="" src="/w/images/1/thumb/d/df/Fig_10_anamiguel_octa_macula_2_devices.png/647px-Fig_10_anamiguel_octa_macula_2_devices.png" decoding="async" width="647" height="204" class="thumbimage" srcset="/w/images/1/thumb/d/df/Fig_10_anamiguel_octa_macula_2_devices.png/971px-Fig_10_anamiguel_octa_macula_2_devices.png 1.5x, /w/images/1/thumb/d/df/Fig_10_anamiguel_octa_macula_2_devices.png/1294px-Fig_10_anamiguel_octa_macula_2_devices.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_10_anamiguel_octa_macula_2_devices.png" class="internal" title="Enlarge"></a></div>Figure 10. Macular OCTA of the same patient with 2 devices.</div></div></div>
<p><br />
</p><p><br />
</p>
<div class="thumb tright"><div class="thumbinner" style="width:650px;"><a href="/File:Fig_11_octa_disc_2_devices.png" class="image"><img alt="" src="/w/images/1/thumb/a/ad/Fig_11_octa_disc_2_devices.png/648px-Fig_11_octa_disc_2_devices.png" decoding="async" width="648" height="208" class="thumbimage" srcset="/w/images/1/thumb/a/ad/Fig_11_octa_disc_2_devices.png/972px-Fig_11_octa_disc_2_devices.png 1.5x, /w/images/1/thumb/a/ad/Fig_11_octa_disc_2_devices.png/1296px-Fig_11_octa_disc_2_devices.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Fig_11_octa_disc_2_devices.png" class="internal" title="Enlarge"></a></div>Figure 11. Optic nerve OCTA of the same patient with two devices.</div></div></div>
<p><br clear="all" />
</p>
<h2><span class="mw-headline" id="Two_OCTA_devices_with_the_same_patient">Two OCTA devices with the same patient</span></h2>
<p>Figures 10 and 11 depict the same patient with two different OCTA devices (Triton on the right and Angiovue on the left). Figure 10 illustrates a macular OCTA scan, while figure 11 shows an optic nerve scan.                                                                                                                                                                                                                                                                                                                                                                                                                
</p>
<h1><span class="mw-headline" id="Conclusion">Conclusion</span></h1>
<p>In conclusion, OCTA is a non-invasive, rapid, and evolving technology that has shown to be valuable in the diagnosis and follow-up of glaucoma, among other ophthalmic pathologies. 
</p><p><br />
</p>
<h1><span class="mw-headline" id="Additional_Resources">Additional Resources</span></h1>
<ul><li>Boyd K, McKinney JK, Turbert D. <a rel="nofollow" class="external text" href="https://www.aao.org/eye-health/diseases/glaucoma-list">Glaucoma</a>. American Academy of Ophthalmology. EyeSmart<sup>®</sup> Eye health. <a rel="nofollow" class="external free" href="https://www.aao.org/eye-health/diseases/glaucoma-list">https://www.aao.org/eye-health/diseases/glaucoma-list</a>. Accessed January 06, 2023.</li>
<li>Porter D, Vemulakonda GA. <a rel="nofollow" class="external text" href="https://www.aao.org/eye-health/anatomy/blood-pressure-list">Blood Pressure</a>. American Academy of Ophthalmology. EyeSmart<sup>®</sup> Eye health. <a rel="nofollow" class="external free" href="https://www.aao.org/eye-health/anatomy/blood-pressure-list">https://www.aao.org/eye-health/anatomy/blood-pressure-list</a>. Accessed January 06, 2023.</li></ul>
<p><br />
<b>Below are some informative OCTA books:</b>
</p>
<ul><li><b>Practical Handbook of OCT Angiography</b> <i>Bruno Lumbroso</i> Jaypee Brothers Medical Publishers (P) Ltd; ISBN&#160;: 9789385999970. 2006</li>
<li><b>Atlas d'Angiographie OCT Clinique</b> <i>B.Lumbroso, D. Huang, C.J. Chen, Y.Jia, M.Rispoli, A.Romano, N.K.Waheed. 2006.</i></li></ul>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-:0-1"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:0_1-0">1.0</a></sup> <sup><a href="#cite_ref-:0_1-1">1.1</a></sup> <sup><a href="#cite_ref-:0_1-2">1.2</a></sup></span> <span class="reference-text"><i>European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 2: Classification and terminology.</i> British Journal of Ophthalmology (2017;101:80-85).</span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><a href="#cite_ref-2">↑</a></span> <span class="reference-text">Quigley, H.A. and A.T. Broman, <i>The number of people with glaucoma worldwide in 2010 and 2020.</i> Br J Ophthalmol, 2006. <b>90</b>(3): p. 262-7.</span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><a href="#cite_ref-3">↑</a></span> <span class="reference-text">Mitchell, P., et al., <i>prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study.</i> Ophthalmology, 1996. <b>103</b>(10): p. 1661-9.</span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><a href="#cite_ref-4">↑</a></span> <span class="reference-text">Keel, S., et al., <i>Prevalence of glaucoma in the Australian National Eye Health Survey.</i> Br J Ophthalmol, 2019. <b>103</b>(2): p. 191-195.</span>
</li>
<li id="cite_note-:6-5"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:6_5-0">5.0</a></sup> <sup><a href="#cite_ref-:6_5-1">5.1</a></sup> <sup><a href="#cite_ref-:6_5-2">5.2</a></sup> <sup><a href="#cite_ref-:6_5-3">5.3</a></sup> <sup><a href="#cite_ref-:6_5-4">5.4</a></sup> <sup><a href="#cite_ref-:6_5-5">5.5</a></sup></span> <span class="reference-text">Miguel, A.I.M., A.B. Silva, and L.F. Azevedo, <i>Diagnostic performance of optical coherence tomography angiography in glaucoma: a systematic review and meta-analysis.</i> Br J Ophthalmol, 2019.</span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><a href="#cite_ref-6">↑</a></span> <span class="reference-text">Fechtner, R.D. and R.N. Weinreb, <i>Mechanisms of optic nerve damage in primary open angle glaucoma.</i> Surv Ophthalmol, 1994. <b>39</b>(1): p. 23-42.</span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><a href="#cite_ref-7">↑</a></span> <span class="reference-text">Yan, D.B., et al., <i>Deformation of the lamina cribrosa by elevated intraocular pressure.</i> Br J Ophthalmol, 1994. <b>78</b>(8): p. 643-8.</span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><a href="#cite_ref-8">↑</a></span> <span class="reference-text">Quigley, H.A., et al., <i>Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma.</i> Am J Ophthalmol, 1983. <b>95</b>(5): p. 673-91.</span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><a href="#cite_ref-9">↑</a></span> <span class="reference-text">Sommer, A., et al., <i>Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.</i> Arch Ophthalmol, 1991. <b>109</b>(8): p. 1090-5.</span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><a href="#cite_ref-10">↑</a></span> <span class="reference-text">Investigators, A., <i>The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty.</i> Am J Ophthalmol, 2002. <b>134</b>(4): p. 481-98.</span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><a href="#cite_ref-11">↑</a></span> <span class="reference-text">Gordon, M.O., et al., <i>The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.</i> Arch Ophthalmol, 2002. <b>120</b>(6): p. 714-20; discussion 829-30.</span>
</li>
<li id="cite_note-:1-12"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:1_12-0">12.0</a></sup> <sup><a href="#cite_ref-:1_12-1">12.1</a></sup></span> <span class="reference-text">Leske, M.C., et al., <i>Predictors of long-term progression in the early manifest glaucoma trial.</i> Ophthalmology, 2007. <b>114</b>(11): p. 1965-72.</span>
</li>
<li id="cite_note-:2-13"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:2_13-0">13.0</a></sup> <sup><a href="#cite_ref-:2_13-1">13.1</a></sup></span> <span class="reference-text">Varma, R., et al., <i>Four-year incidence of open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study.</i> Am J Ophthalmol, 2012. <b>154</b>(2): p. 315-325 e1.</span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><a href="#cite_ref-14">↑</a></span> <span class="reference-text">Jampel, H.D., et al., <i>Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS).</i> Am J Ophthalmol, 2005. <b>140</b>(1): p. 16-22.</span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><a href="#cite_ref-15">↑</a></span> <span class="reference-text">Robert N. Weinreb, T.A., Felipe A. Medeiros. , <i>The Pathophysiology and Treatment of Glaucoma: A Review.</i> JAMA - Journal of the American Medical Association, 2014 <b>311(18): 1901–1911. doi:&#160; 10.1001/jama.2014.3192</b> </span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><a href="#cite_ref-16">↑</a></span> <span class="reference-text">Flammer, J., <i>The vascular concept of glaucoma.</i> Surv Ophthalmol, 1994. <b>38 Suppl</b>: p. S3-6.</span>
</li>
<li id="cite_note-:3-17"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:3_17-0">17.0</a></sup> <sup><a href="#cite_ref-:3_17-1">17.1</a></sup> <sup><a href="#cite_ref-:3_17-2">17.2</a></sup></span> <span class="reference-text">Bonomi, L., et al., <i>Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study.</i> Ophthalmology, 2000. <b>107</b>(7): p. 1287-93.</span>
</li>
<li id="cite_note-:4-18"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:4_18-0">18.0</a></sup> <sup><a href="#cite_ref-:4_18-1">18.1</a></sup></span> <span class="reference-text">Schmidl, D., G. Garhofer, and L. Schmetterer, <i>The complex interaction between ocular perfusion pressure and ocular blood flow - relevance for glaucoma.</i> Exp Eye Res, 2011. <b>93</b>(2): p. 141-55.</span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><a href="#cite_ref-19">↑</a></span> <span class="reference-text">Mottet, B., et al., <i>Vascular factors in glaucoma.</i> Journal Francais d'Ophtalmologie, 2015. <b>38</b>(10): p. 983-995.</span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><a href="#cite_ref-20">↑</a></span> <span class="reference-text">Schmetterer, L. and K. Polak, <i>Role of nitric oxide in the control of ocular blood flow.</i> Prog Retin Eye Res, 2001. <b>20</b>(6): p. 823-47.</span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><a href="#cite_ref-21">↑</a></span> <span class="reference-text">Ghanem, A.A., A.M. Elewa, and L.F. Arafa, <i>Endothelin-1 and nitric oxide levels in patients with glaucoma.</i> Ophthalmic Res, 2011. <b>46</b>(2): p. 98-102.</span>
</li>
<li id="cite_note-:5-22"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:5_22-0">22.0</a></sup> <sup><a href="#cite_ref-:5_22-1">22.1</a></sup></span> <span class="reference-text">Toda, N. and M. Nakanishi-Toda, <i>Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.</i> Prog Retin Eye Res, 2007. <b>26</b>(3): p. 205-38.</span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><a href="#cite_ref-23">↑</a></span> <span class="reference-text">Polak, K., et al., <i>Regulation of human retinal blood flow by endothelin-1.</i> Exp Eye Res, 2003. <b>76</b>(5): p. 633-40.</span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><a href="#cite_ref-24">↑</a></span> <span class="reference-text">Dielemans, I., et al., <i>Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study.</i> Ophthalmology, 1995. <b>102</b>(1): p. 54-60.</span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><a href="#cite_ref-25">↑</a></span> <span class="reference-text">Bulpitt, C.J., C. Hodes, and M.G. Everitt, <i>Intraocular pressure and systemic blood pressure in the elderly.</i> Br J Ophthalmol, 1975. <b>59</b>(12): p. 717-20.</span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><a href="#cite_ref-26">↑</a></span> <span class="reference-text">Bulpitt, C.J., C. Hodes, and M.G. Everitt, <i>Intraocular pressure and systemic blood pressure in the elderly.</i> Br J Ophthalmol, 1975. <b>59</b>(12): p. 717-20.</span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><a href="#cite_ref-27">↑</a></span> <span class="reference-text">Tielsch, J.M., et al., <i>Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment.</i> Arch Ophthalmol, 1995. <b>113</b>(2): p. 216-21.</span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><a href="#cite_ref-28">↑</a></span> <span class="reference-text">Tokunaga, T., et al., <i>Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma.</i> Jpn J Ophthalmol, 2004. <b>48</b>(4): p. 380-5.</span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><a href="#cite_ref-29">↑</a></span> <span class="reference-text">Tokunaga, T., et al., <i>Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma.</i> Jpn J Ophthalmol, 2004. <b>48</b>(4): p. 380-5.</span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><a href="#cite_ref-30">↑</a></span> <span class="reference-text">Kaiser, H.J., et al., <i>Systemic blood pressure in glaucoma patients.</i> Graefes Arch Clin Exp Ophthalmol, 1993. <b>231</b>(12): p. 677-80.</span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><a href="#cite_ref-31">↑</a></span> <span class="reference-text">Drance, S., et al., <i>Risk factors for progression of visual field abnormalities in normal-tension glaucoma.</i> Am J Ophthalmol, 2001. <b>131</b>(6): p. 699-708.</span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><a href="#cite_ref-32">↑</a></span> <span class="reference-text">Gasser, P. and J. Flammer, <i>Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma.</i> Am J Ophthalmol, 1991. <b>111</b>(5): p. 585-8.</span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><a href="#cite_ref-33">↑</a></span> <span class="reference-text">Francois, J. and A. Fryczkowski, <i>The blood supply of the optic nerve.</i> Adv Ophthalmol, 1978. <b>36</b>: p. 164-73.</span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><a href="#cite_ref-34">↑</a></span> <span class="reference-text">Potts, A.M., <i>The blood supply of the optic nerve and optic papilla.</i> Trans Am Acad Ophthalmol Otolaryngol, 1969. <b>73</b>(5): p. 886-9.</span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><a href="#cite_ref-35">↑</a></span> <span class="reference-text">Vail, D., <i>The blood supply of the optic nerve and its clinical significance.</i> Am J Ophthalmol, 1948. <b>31</b>(1): p. 1-12.</span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><a href="#cite_ref-36">↑</a></span> <span class="reference-text">van Overbeeke, J. and L. Sekhar, <i>Microanatomy of the blood supply to the optic nerve.</i> Orbit, 2003. <b>22</b>(2): p. 81-8.</span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><a href="#cite_ref-37">↑</a></span> <span class="reference-text">Hollo, G., <i>Peripapillary circle of Zinn-Haller revealed by fundus fluorescein angiography.</i> Br J Ophthalmol, 1998. <b>82</b>(3): p. 332-3.</span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><a href="#cite_ref-38">↑</a></span> <span class="reference-text">Park, K.H., et al., <i>In vivo detection of perineural circular arterial anastomosis (circle of Zinn-Haller) in a patient with large peripapillary chorioretinal atrophy.</i> Am J Ophthalmol, 1996. <b>122</b>(6): p. 905-7.</span>
</li>
<li id="cite_note-:7-39"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:7_39-0">39.0</a></sup> <sup><a href="#cite_ref-:7_39-1">39.1</a></sup></span> <span class="reference-text">Bussel, II, G. Wollstein, and J.S. Schuman, <i>OCT for glaucoma diagnosis, screening and detection of glaucoma progression.</i> Br J Ophthalmol, 2014. <b>98 Suppl 2</b>: p. ii15-9.</span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><a href="#cite_ref-40">↑</a></span> <span class="reference-text">Bockova, M., et al., <i>Sensitivity and specificity of spectral OCT in patients with early glaucoma.</i> Cesk Slov Oftalmol, 2019. <b>75</b>(5): p. 260-264.</span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><a href="#cite_ref-41">↑</a></span> <span class="reference-text">Vidotti, V.G., et al., <i>Sensitivity and specificity of machine learning classifiers and spectral domain OCT for the diagnosis of glaucoma.</i> Eur J Ophthalmol, 2012: p. 125.</span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><a href="#cite_ref-42">↑</a></span> <span class="reference-text">Fujimoto, J.G., <i>Optical coherence tomography for ultrahigh resolution in vivo imaging.</i> Nature Biotechnology, 2003. <b>21</b>(11): p. 1361-1367.</span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><a href="#cite_ref-43">↑</a></span> <span class="reference-text">Fercher, A.F., K. Mengedoht, and W. Werner, <i>Eye-length measurement by interferometry with partially coherent light.</i> Opt Lett, 1988. <b>13</b>(3): p. 186-8.</span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><a href="#cite_ref-44">↑</a></span> <span class="reference-text">Huang, D., et al., <i>Optical coherence tomography.</i> Science, 1991. <b>254</b>(5035): p. 1178-81.</span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><a href="#cite_ref-45">↑</a></span> <span class="reference-text">Leitgeb, R., C. Hitzenberger, and A. Fercher, <i>Performance of fourier domain vs. time domain optical coherence tomography.</i> Opt Express, 2003. <b>11</b>(8): p. 889-94.</span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><a href="#cite_ref-46">↑</a></span> <span class="reference-text">Zheng, K., et al., <i>Experimental confirmation of potential swept source optical coherence tomography performance limitations.</i> Appl Opt, 2008. <b>47</b>(33): p. 6151-8.</span>
</li>
<li id="cite_note-:8-47"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:8_47-0">47.0</a></sup> <sup><a href="#cite_ref-:8_47-1">47.1</a></sup></span> <span class="reference-text">Jia, Y., et al., <i>Split-spectrum amplitude-decorrelation angiography with optical coherence tomography.</i> Opt Express, 2012. <b>20</b>(4): p. 4710-25.</span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><a href="#cite_ref-48">↑</a></span> <span class="reference-text">Zhang, A., et al., <i>Methods and algorithms for optical coherence tomography-based angiography: A review and comparison.</i> Journal of Biomedical Optics, 2015. <b>20</b>(10).</span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><a href="#cite_ref-49">↑</a></span> <span class="reference-text">An, L., M. Johnstone, and R.K. Wang, <i>Optical microangiography provides correlation between microstructure and microvasculature of optic nerve head in human subjects.</i> J Biomed Opt, 2012. <b>17</b>(11): p. 116018.</span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><a href="#cite_ref-50">↑</a></span> <span class="reference-text">Zhang, A., et al., <i>Methods and algorithms for optical coherence tomography-based angiography: a review and comparison.</i> J Biomed Opt, 2015. <b>20</b>(10): p. 100901.</span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><a href="#cite_ref-51">↑</a></span> <span class="reference-text">Liu, L., et al., <i>Projection-Resolved Optical Coherence Tomography Angiography of the Peripapillary Retina in Glaucoma.</i> Am J Ophthalmol, 2019. <b>207</b>: p. 99-109.</span>
</li>
<li id="cite_note-:9-52"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:9_52-0">52.0</a></sup> <sup><a href="#cite_ref-:9_52-1">52.1</a></sup></span> <span class="reference-text">Takusagawa, H.L., et al., <i>Projection-Resolved Optical Coherence Tomography Angiography of Macular Retinal Circulation in Glaucoma.</i> Ophthalmology, 2017. <b>124</b>(11): p. 1589-1599.</span>
</li>
<li id="cite_note-:10-53"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:10_53-0">53.0</a></sup> <sup><a href="#cite_ref-:10_53-1">53.1</a></sup></span> <span class="reference-text">Mansoori, T., et al., <i>Radial Peripapillary Capillary Density Measurement Using Optical Coherence Tomography Angiography in Early Glaucoma.</i> J Glaucoma, 2017. <b>26</b>(5): p. 438-443.</span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><a href="#cite_ref-54">↑</a></span> <span class="reference-text">Liu, L., et al., <i>Optical Coherence Tomography Angiography of the Peripapillary Retina in Glaucoma.</i> JAMA Ophthalmol, 2015. <b>133</b>(9): p. 1045-52.</span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><a href="#cite_ref-55">↑</a></span> <span class="reference-text">Shin, J.W., et al., <i>Regional vascular density-visual field sensitivity relationship in glaucoma according to disease severity.</i> Br J Ophthalmol, 2017. <b>101</b>(12): p. 1666-1672.</span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><a href="#cite_ref-56">↑</a></span> <span class="reference-text">Yarmohammadi, A., et al., <i>Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss.</i> Ophthalmology, 2018. <b>125</b>(4): p. 578-587.</span>
</li>
<li id="cite_note-:11-57"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:11_57-0">57.0</a></sup> <sup><a href="#cite_ref-:11_57-1">57.1</a></sup> <sup><a href="#cite_ref-:11_57-2">57.2</a></sup></span> <span class="reference-text">Suh, M.H., et al., <i>Deep Retinal Layer Microvasculature Dropout Detected by the Optical Coherence Tomography Angiography in Glaucoma.</i> Ophthalmology, 2016. <b>123</b>(12): p. 2509-2518.</span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><a href="#cite_ref-58">↑</a></span> <span class="reference-text">Lee, E.J., et al., <i>Underlying Microstructure of Parapapillary Deep-Layer Capillary Dropout Identified by Optical Coherence Tomography Angiography.</i> Invest Ophthalmol Vis Sci, 2017. <b>58</b>(3): p. 1621-1627.</span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><a href="#cite_ref-59">↑</a></span> <span class="reference-text">Bojikian, K.D., P.P. Chen, and J.C. Wen, <i>Optical coherence tomography angiography in glaucoma.</i> Curr Opin Ophthalmol, 2019. <b>30</b>(2): p. 110-116.</span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><a href="#cite_ref-60">↑</a></span> <span class="reference-text">Lee, E.J., et al., <i>Parapapillary Deep-Layer Microvasculature Dropout in Glaucoma: Topographic Association With Glaucomatous Damage.</i> Invest Ophthalmol Vis Sci, 2017. <b>58</b>(7): p. 3004-3010.</span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><a href="#cite_ref-61">↑</a></span> <span class="reference-text">Park, H.L., J.W. Kim, and C.K. Park, <i>Choroidal Microvasculature Dropout Is Associated with Progressive Retinal Nerve Fiber Layer Thinning in Glaucoma with Disc Hemorrhage.</i> Ophthalmology, 2018. <b>125</b>(7): p. 1003-1013.</span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><a href="#cite_ref-62">↑</a></span> <span class="reference-text">Shin, J.W., et al., <i>Choroidal Microvasculature Dropout is Not Associated With Myopia, But is Associated With Glaucoma.</i> J Glaucoma, 2018. <b>27</b>(2): p. 189-196.</span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><a href="#cite_ref-63">↑</a></span> <span class="reference-text">Kwon, J.M., et al., <i>Parapapillary Deep-Layer Microvasculature Dropout and Visual Field Progression in Glaucoma.</i> Am J Ophthalmol, 2019. <b>200</b>: p. 65-75.</span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><a href="#cite_ref-64">↑</a></span> <span class="reference-text">Chen, H.S., et al., <i>Optical Coherence Tomography Angiography of the Superficial Microvasculature in the Macular and Peripapillary Areas in Glaucomatous and Healthy Eyes.</i> Invest Ophthalmol Vis Sci, 2017. <b>58</b>(9): p. 3637-3645.</span>
</li>
<li id="cite_note-:15-65"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:15_65-0">65.0</a></sup> <sup><a href="#cite_ref-:15_65-1">65.1</a></sup> <sup><a href="#cite_ref-:15_65-2">65.2</a></sup></span> <span class="reference-text">Rao, H.L., et al., <i>Diagnostic ability of peripapillary vessel density measurements of optical coherence tomography angiography in primary open-angle and angle-closure glaucoma.</i> Br J Ophthalmol, 2017. <b>101</b>(8): p. 1066-1070.</span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><a href="#cite_ref-66">↑</a></span> <span class="reference-text">Chung, J.K., et al., <i>Glaucoma Diagnostic Ability of the Optical Coherence Tomography Angiography Vessel Density Parameters.</i> Curr Eye Res, 2017. <b>42</b>(11): p. 1458-1467.</span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><a href="#cite_ref-67">↑</a></span> <span class="reference-text">Shin, J.W., et al., <i>Relationship between vessel density and visual field sensitivity in glaucomatous eyes with high myopia.</i> Br J Ophthalmol, 2018.</span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><a href="#cite_ref-68">↑</a></span> <span class="reference-text">Ghahari, E., et al., <i>Association of Macular and Circumpapillary Microvasculature with Visual Field Sensitivity in Advanced Glaucoma.</i> Am J Ophthalmol, 2019. <b>204</b>: p. 51-61.</span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><a href="#cite_ref-69">↑</a></span> <span class="reference-text">Werner, A.C. and L.Q. Shen, <i>A Review of OCT Angiography in Glaucoma.</i> Semin Ophthalmol, 2019. <b>34</b>(4): p. 279-286.</span>
</li>
<li id="cite_note-:16-70"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:16_70-0">70.0</a></sup> <sup><a href="#cite_ref-:16_70-1">70.1</a></sup> <sup><a href="#cite_ref-:16_70-2">70.2</a></sup></span> <span class="reference-text">Miguel, A., et al., <i>OCT-angiography detects longitudinal microvascular changes in glaucoma: a systematic review.</i> Br J Ophthalmol, 2021.</span>
</li>
<li id="cite_note-:12-71"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:12_71-0">71.0</a></sup> <sup><a href="#cite_ref-:12_71-1">71.1</a></sup></span> <span class="reference-text">Park, H.Y., et al., <i>Association Between Parapapillary Choroidal Vessel Density Measured With Optical Coherence Tomography Angiography and Future Visual Field Progression in Patients With Glaucoma.</i> JAMA Ophthalmol, 2019. <b>137</b>(6): p. 681-688.</span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><a href="#cite_ref-72">↑</a></span> <span class="reference-text">Shin, J.W., et al., <i>Peripapillary Microvascular Improvement and Lamina Cribrosa Depth Reduction After Trabeculectomy in Primary Open-Angle Glaucoma.</i> Invest Ophthalmol Vis Sci, 2017. <b>58</b>(13): p. 5993-5999.</span>
</li>
<li id="cite_note-:13-73"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:13_73-0">73.0</a></sup> <sup><a href="#cite_ref-:13_73-1">73.1</a></sup> <sup><a href="#cite_ref-:13_73-2">73.2</a></sup> <sup><a href="#cite_ref-:13_73-3">73.3</a></sup></span> <span class="reference-text">Lommatzsch, C., et al., <i>Retinal perfusion 6 months after trabeculectomy as measured by optical coherence tomography angiography.</i> 2019.</span>
</li>
<li id="cite_note-:14-74"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:14_74-0">74.0</a></sup> <sup><a href="#cite_ref-:14_74-1">74.1</a></sup></span> <span class="reference-text">Hollo, G., <i>Influence of Removing the Large Retinal Vessels-related Effect on Peripapillary Vessel Density Progression Analysis in Glaucoma.</i> J Glaucoma, 2018. <b>27</b>(8): p. e137-e139.</span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><a href="#cite_ref-75">↑</a></span> <span class="reference-text">Moghimi, S., et al., <i>Macular and Optic Nerve Head Vessel Density and Progressive Retinal Nerve Fiber Layer Loss in Glaucoma.</i> Ophthalmology, 2018. <b>125</b>(11): p. 1720-1728.</span>
</li>
<li id="cite_note-:17-76"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:17_76-0">76.0</a></sup> <sup><a href="#cite_ref-:17_76-1">76.1</a></sup></span> <span class="reference-text">Shin, J.W., et al., <i>Peripapillary Microvascular Improvement and Lamina Cribrosa Depth Reduction After Trabeculectomy in Primary Open-Angle Glaucoma.</i> Invest Ophthalmol Vis Sci, 2017. <b>58</b>(13): p. 5993-5999.</span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><a href="#cite_ref-77">↑</a></span> <span class="reference-text">Shoji, T., et al., <i>Progressive Macula Vessel Density Loss in Primary Open-Angle Glaucoma: A Longitudinal Study.</i> Am J Ophthalmol, 2017. <b>182</b>: p. 107-117.</span>
</li>
<li id="cite_note-:18-78"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:18_78-0">78.0</a></sup> <sup><a href="#cite_ref-:18_78-1">78.1</a></sup> <sup><a href="#cite_ref-:18_78-2">78.2</a></sup></span> <span class="reference-text">Ch’ng, T.W., et al., <i>- Effect of surgical intraocular pressure lowering on retinal structures-nerve fibre layer, foveal avascular zone, peripapillary and macular vessel density: 1 year results.</i> 2019: p. 110.</span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><a href="#cite_ref-79">↑</a></span> <span class="reference-text">Trible, J.R., et al., <i>Trabeculectomy is associated with retrobulbar hemodynamic changes. A color Doppler analysis.</i> Ophthalmology, 1994. <b>101</b>(2): p. 340-51.</span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><a href="#cite_ref-80">↑</a></span> <span class="reference-text">Kuerten, D., et al., <i>Long term effect of trabeculectomy on retrobulbar haemodynamics in glaucoma.</i> Ophthalmic Physiol Opt, 2015. <b>35</b>(2): p. 194-200.</span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><a href="#cite_ref-81">↑</a></span> <span class="reference-text">Berisha, F., et al., <i>Effect of trabeculectomy on ocular blood flow.</i> Br J Ophthalmol, 2005. <b>89</b>(2): p. 185-8.</span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><a href="#cite_ref-82">↑</a></span> <span class="reference-text">In, J.H., et al., <i>Peripapillary Vessel Density Reversal after Trabeculectomy in Glaucoma.</i> J Ophthalmol, 2018. <b>2018</b>: p. 8909714.</span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><a href="#cite_ref-83">↑</a></span> <span class="reference-text">Kim, J.A., et al., <i>Microvascular Changes in Peripapillary and Optic Nerve Head Tissues After Trabeculectomy in Primary Open-Angle Glaucoma.</i> Investigative Ophthalmology &amp; Visual Science, 2018. <b>59</b>(11): p. 4614-4621.</span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><a href="#cite_ref-84">↑</a></span> <span class="reference-text">Landers, J., et al., <i>A twenty-year follow-up study of trabeculectomy: risk factors and outcomes.</i> Ophthalmology, 2012. <b>119</b>(4): p. 694-702.</span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><a href="#cite_ref-85">↑</a></span> <span class="reference-text">Joseph, J.P., M.H. Miller, and R.A. Hitchings, <i>Wound healing as a barrier to successful filtration surgery.</i> Eye (Lond), 1988. <b>2 Suppl</b>: p. S113-23.</span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><a href="#cite_ref-86">↑</a></span> <span class="reference-text">Cantor, L.B., et al., <i>Morphologic classification of filtering blebs after glaucoma filtration surgery: the Indiana Bleb Appearance Grading Scale.</i> J Glaucoma, 2003. <b>12</b>(3): p. 266-71.</span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><a href="#cite_ref-87">↑</a></span> <span class="reference-text">Wen, J.C., S.S. Stinnett, and S. Asrani, <i>Comparison of Anterior Segment Optical Coherence Tomography Bleb Grading, Moorfields Bleb Grading System, and Intraocular Pressure After Trabeculectomy.</i> J Glaucoma, 2017. <b>26</b>(5): p. 403-408.</span>
</li>
<li id="cite_note-88"><span class="mw-cite-backlink"><a href="#cite_ref-88">↑</a></span> <span class="reference-text">Richter, G.M., <i>The Promise of Optical Coherence Tomography Angiography in Glaucoma.</i> Ophthalmology, 2017. <b>124</b>(11): p. 1577-1578.</span>
</li>
<li id="cite_note-89"><span class="mw-cite-backlink"><a href="#cite_ref-89">↑</a></span> <span class="reference-text">Yin, X., et al., <i>Relationship between filtering bleb vascularization and surgical outcomes after trabeculectomy: an optical coherence tomography angiography study.</i> Graefes Arch Clin Exp Ophthalmol, 2018. <b>256</b>(12): p. 2399-2405.</span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><a href="#cite_ref-90">↑</a></span> <span class="reference-text">Seo, J.H., et al., <i>Evaluation of Functional Filtering Bleb Using Optical Coherence Tomography Angiography.</i> Translational Vision Science &amp; Technology, 2019. <b>8</b>(3).</span>
</li>
<li id="cite_note-:19-91"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:19_91-0">91.0</a></sup> <sup><a href="#cite_ref-:19_91-1">91.1</a></sup></span> <span class="reference-text">Hayek, S., et al., <i>Optical Coherence Tomography Angiography Evaluation of Conjunctival Vessels During Filtering Surgery.</i> Transl Vis Sci Technol, 2019. <b>8</b>(4): p. 4.</span>
</li>
<li id="cite_note-92"><span class="mw-cite-backlink"><a href="#cite_ref-92">↑</a></span> <span class="reference-text">Mastropasqua, R., et al., <i>Angiographic biomarkers of filtering bleb function after XEN gel implantation for glaucoma: an optical coherence tomography-angiography study.</i> Acta Ophthalmol, 2020. <b>98</b>(6): p. e761-e767.</span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><a href="#cite_ref-93">↑</a></span> <span class="reference-text">Monteiro-Henriques, I., A. Rocha-Sousa, and J. Barbosa-Breda, <i>Optical coherence tomography angiography changes in cardiovascular systemic diseases and risk factors: A Review.</i> Acta Ophthalmol, 2021, p95</span>
</li>
<li id="cite_note-94"><span class="mw-cite-backlink"><a href="#cite_ref-94">↑</a></span> <span class="reference-text">Zhang, B., et al., <i>Early Detection of Microvascular Impairments With Optical Coherence Tomography Angiography in Diabetic Patients Without Clinical Retinopathy: A Meta-analysis.</i> Am J Ophthalmol, 2021. <b>222</b>: p. 226-237.</span>
</li>
<li id="cite_note-:20-95"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:20_95-0">95.0</a></sup> <sup><a href="#cite_ref-:20_95-1">95.1</a></sup></span> <span class="reference-text">Tsokolas, G., et al., <i>Optical Coherence Tomography Angiography in Neurodegenerative Diseases: A Review.</i> Eye Brain, 2020. <b>12</b>: p. 73-87.</span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><a href="#cite_ref-96">↑</a></span> <span class="reference-text">Ayar, K., et al., <i>Evaluation of retinal vascularization by optical coherence tomography angiography (OCTA) in rheumatoid arthritis, and its relationship with disease activity. Mod Rheumatol, 2020: p. 1-10.</i></span>
</li>
<li id="cite_note-97"><span class="mw-cite-backlink"><a href="#cite_ref-97">↑</a></span> <span class="reference-text">Crisostomo, S., et al., <i>TAMOXIFEN-INDUCED CHORIORETINAL CHANGES: An Optical Coherence Tomography and Optical Coherence Tomography Angiography Study.</i> Retina, 2020. <b>40</b>(6): p. 1185-1190.</span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><a href="#cite_ref-98">↑</a></span> <span class="reference-text">Cennamo, G., et al., <i>Optical Coherence Tomography Angiography Features in Post-COVID-19 Pneumonia Patients: A Pilot Study.</i> Am J Ophthalmol, 2021. <b>227</b>: p. 182-190.</span>
</li>
<li id="cite_note-99"><span class="mw-cite-backlink"><a href="#cite_ref-99">↑</a></span> <span class="reference-text">Garcia-Martin, E., et al., <i>Retinal and Optic Nerve Degeneration in Patients with Multiple Sclerosis Followed up for 5 Years.</i> Ophthalmology, 2017. <b>124</b>(5): p. 688-696.</span>
</li>
<li id="cite_note-:21-100"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:21_100-0">100.0</a></sup> <sup><a href="#cite_ref-:21_100-1">100.1</a></sup></span> <span class="reference-text">Lanzillo, R., et al., <i>Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis.</i> Mult Scler, 2018. <b>24</b>(13): p. 1706-1714.</span>
</li>
<li id="cite_note-:22-101"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:22_101-0">101.0</a></sup> <sup><a href="#cite_ref-:22_101-1">101.1</a></sup></span> <span class="reference-text">Farci, R., et al., <i>Optical coherence tomography angiography in multiple sclerosis: A cross-sectional study.</i> PLoS One, 2020. <b>15</b>(7): p. e0236090.</span>
</li>
<li id="cite_note-102"><span class="mw-cite-backlink"><a href="#cite_ref-102">↑</a></span> <span class="reference-text">Feucht, N., et al., <i>Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis.</i> Mult Scler, 2019. <b>25</b>(2): p. 224-234.</span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><a href="#cite_ref-103">↑</a></span> <span class="reference-text">Wang, X., et al., <i>Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis.</i> Br J Ophthalmol, 2014. <b>98</b>(10): p. 1368-73.</span>
</li>
<li id="cite_note-104"><span class="mw-cite-backlink"><a href="#cite_ref-104">↑</a></span> <span class="reference-text">Hayreh, S.S., <i>Ischemic optic neuropathies - where are we now?</i> Graefes Arch Clin Exp Ophthalmol, 2013. <b>251</b>(8): p. 1873-84.</span>
</li>
<li id="cite_note-105"><span class="mw-cite-backlink"><a href="#cite_ref-105">↑</a></span> <span class="reference-text">Wang, H., et al., <i>Macular evaluation of the retinal and choroidal vasculature changes in anterior ischemic optic neuropathy-a case control study.</i> BMC Ophthalmol, 2018. <b>18</b>(1): p. 341.</span>
</li>
<li id="cite_note-:23-106"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:23_106-0">106.0</a></sup> <sup><a href="#cite_ref-:23_106-1">106.1</a></sup></span> <span class="reference-text">Pierro, L., et al., <i>Vessel Density and Vessel Tortuosity Quantitative Analysis of Arteritic and Non-arteritic Anterior Ischemic Optic Neuropathies: An Optical Coherence Tomography Angiography Study.</i> J Clin Med, 2020. <b>9</b>(4).</span>
</li>
<li id="cite_note-:24-107"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:24_107-0">107.0</a></sup> <sup><a href="#cite_ref-:24_107-1">107.1</a></sup></span> <span class="reference-text">Augstburger, E., et al., <i>Retinal and Choroidal Microvasculature in Nonarteritic Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomography Angiography Study.</i> Invest Ophthalmol Vis Sci, 2018. <b>59</b>(2): p. 870-877.</span>
</li>
<li id="cite_note-108"><span class="mw-cite-backlink"><a href="#cite_ref-108">↑</a></span> <span class="reference-text">Rougier, M.B., et al., <i>OCT angiography analysis in acute non-arteritic anterior ischemic optic neuropathy: The importance of segmentation.</i> Eur J Ophthalmol, 2020: p. 1120672120978358.</span>
</li>
<li id="cite_note-109"><span class="mw-cite-backlink"><a href="#cite_ref-109">↑</a></span> <span class="reference-text">Chuang, J.C., et al., <i>Comparison of Peripapillary Vessel Density of Acute Nonarteritic Anterior Ischemic Optic Neuropathy and Other Optic Neuropathies With Disc Swelling Using Optical Coherence Tomography Angiography: A Pilot Study.</i> J Neuroophthalmol, 2020.</span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><a href="#cite_ref-110">↑</a></span> <span class="reference-text">Smith, J.L., W.F. Hoyt, and J.O. Susac, <i>Ocular fundus in acute Leber optic neuropathy.</i> Arch Ophthalmol, 1973. <b>90</b>(5): p. 349-54.</span>
</li>
<li id="cite_note-111"><span class="mw-cite-backlink"><a href="#cite_ref-111">↑</a></span> <span class="reference-text">Balducci, N., et al., <i>Peripapillary vessel density changes in Leber's hereditary optic neuropathy: a new biomarker.</i> Clin Exp Ophthalmol, 2018. <b>46</b>(9): p. 1055-1062.</span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><a href="#cite_ref-112">↑</a></span> <span class="reference-text">Borrelli, E., et al., <i>Topographic Macular Microvascular Changes and Correlation With Visual Loss in Chronic Leber Hereditary Optic Neuropathy.</i> Am J Ophthalmol, 2018. <b>192</b>: p. 217-228.</span>
</li>
<li id="cite_note-113"><span class="mw-cite-backlink"><a href="#cite_ref-113">↑</a></span> <span class="reference-text">Chun, B.Y. and J.F. Rizzo, 3rd, <i>Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.</i> Semin Pediatr Neurol, 2017. <b>24</b>(2): p. 129-134.</span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><a href="#cite_ref-114">↑</a></span> <span class="reference-text">Martins, A., et al., <i>Peripapillary and macular morpho-vascular changes in patients with genetic or clinical diagnosis of autosomal dominant optic atrophy: a case-control study.</i> Graefes Arch Clin Exp Ophthalmol, 2019. <b>257</b>(5): p. 1019-1027.</span>
</li>
<li id="cite_note-115"><span class="mw-cite-backlink"><a href="#cite_ref-115">↑</a></span> <span class="reference-text">Fard, M.A., et al., <i>Optical Coherence Tomography Angiography in Optic Disc Swelling.</i> Am J Ophthalmol, 2018. <b>191</b>: p. 116-123.</span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><a href="#cite_ref-116">↑</a></span> <span class="reference-text">Tuntas Bilen, F. and H. Atilla, <i>Peripapillary Vessel Density Measured by Optical Coherence Tomography Angiography in Idiopathic Intracranial Hypertension.</i> J Neuroophthalmol, 2019. <b>39</b>(3): p. 319-323.</span>
</li>
<li id="cite_note-:25-117"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:25_117-0">117.0</a></sup> <sup><a href="#cite_ref-:25_117-1">117.1</a></sup></span> <span class="reference-text">Fard, M.A., et al., <i>Optical Coherence Tomography Angiography in Papilledema Compared With Pseudopapilledema.</i> Invest Ophthalmol Vis Sci, 2019. <b>60</b>(1): p. 168-175.</span>
</li>
<li id="cite_note-:26-118"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:26_118-0">118.0</a></sup> <sup><a href="#cite_ref-:26_118-1">118.1</a></sup></span> <span class="reference-text">Malmqvist, L., et al., <i>The Optic Disc Drusen Studies Consortium Recommendations for Diagnosis of Optic Disc Drusen Using Optical Coherence Tomography.</i> J Neuroophthalmol, 2018. <b>38</b>(3): p. 299-307.</span>
</li>
<li id="cite_note-:27-119"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:27_119-0">119.0</a></sup> <sup><a href="#cite_ref-:27_119-1">119.1</a></sup></span> <span class="reference-text">Yan, Y., et al., <i>Vision Loss in Optic Disc Drusen Correlates With Increased Macular Vessel Diameter and Flux and Reduced Peripapillary Vascular Density.</i> Am J Ophthalmol, 2020. <b>218</b>: p. 214-224.</span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><a href="#cite_ref-120">↑</a></span> <span class="reference-text">Kim, M.S., et al., <i>Morphologic Features of Buried Optic Disc Drusen on En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography.</i> Am J Ophthalmol, 2020. <b>213</b>: p. 125-133.</span>
</li>
<li id="cite_note-121"><span class="mw-cite-backlink"><a href="#cite_ref-121">↑</a></span> <span class="reference-text">Parrozzani, R., et al., <i>Retinal Vascular and Neural Remodeling Secondary to Optic Nerve Axonal Degeneration: A Study Using OCT Angiography.</i> Ophthalmol Retina, 2018. <b>2</b>(8): p. 827-835.</span>
</li>
<li id="cite_note-122"><span class="mw-cite-backlink"><a href="#cite_ref-122">↑</a></span> <span class="reference-text">Suzuki, A.C.F., et al., <i>Circumpapillary and macular vessel density assessment by optical coherence tomography angiography in eyes with temporal hemianopia from chiasmal compression. Correlation with retinal neural and visual field loss.</i> Eye (Lond), 2020. <b>34</b>(4): p. 695-703.</span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><a href="#cite_ref-123">↑</a></span> <span class="reference-text">Kanamori, A., et al., <i>Optical coherence tomography detects characteristic retinal nerve fiber layer thickness corresponding to band atrophy of the optic discs.</i> Ophthalmology, 2004. <b>111</b>(12): p. 2278-83.</span>
</li>
<li id="cite_note-124"><span class="mw-cite-backlink"><a href="#cite_ref-124">↑</a></span> <span class="reference-text">Lee, G.I., et al., <i>Analysis of Optic Chiasmal Compression Caused by Brain Tumors Using Optical Coherence Tomography Angiography.</i> Sci Rep, 2020. <b>10</b>(1): p. 2088.</span>
</li>
<li id="cite_note-125"><span class="mw-cite-backlink"><a href="#cite_ref-125">↑</a></span> <span class="reference-text">Jaumandreu, L., et al., <i>Reduced Peripapillary and Macular Vessel Density in Unilateral Postgeniculate Lesions With Retrograde Transsynaptic Degeneration.</i> J Neuroophthalmol, 2019. <b>39</b>(4): p. 462-469.</span>
</li>
<li id="cite_note-126"><span class="mw-cite-backlink"><a href="#cite_ref-126">↑</a></span> <span class="reference-text">Skalet, A.H., et al., <i>Quantitative OCT Angiography Evaluation of Peripapillary Retinal Circulation after Plaque Brachytherapy.</i> Ophthalmol Retina, 2018. <b>2</b>(3): p. 244-250.</span>
</li>
<li id="cite_note-127"><span class="mw-cite-backlink"><a href="#cite_ref-127">↑</a></span> <span class="reference-text">Parrozzani, R., et al., <i>Peripapillary vascular changes in radiation optic neuropathy: an optical coherence tomography angiography grading.</i> Br J Ophthalmol, 2018. <b>102</b>(9): p. 1238-1243.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035200
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.036 seconds
CPU time usage: 0.480 seconds
Real time usage: 3.792 seconds
Preprocessor visited node count: 2081/1000000
Post‐expand include size: 7581/2097152 bytes
Template argument size: 2166/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 58030/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 1022.181      1 Template:Article
100.00% 1022.181      1 -total
 89.85%  918.415      4 Template:Infobox_section
 14.49%  148.096      6 Template:UserLookup
  2.99%   30.523      1 Template:Review_expired
  2.22%   22.733      1 Template:Get_active_contest
  1.30%   13.293      1 Template:Infobox_begin
  0.09%    0.927      1 Template:Infobox_end
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=OCT-Angiography_and_Glaucoma&amp;oldid=89567">https://eyewiki.org/w/index.php?title=OCT-Angiography_and_Glaucoma&amp;oldid=89567</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzyyuvku">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/OCT-Angiography_and_Glaucoma" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/OCT-Angiography_and_Glaucoma" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=OCT-Angiography_and_Glaucoma&amp;oldid=89567" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=OCT-Angiography_and_Glaucoma&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on February 10, 2023, at 10:50.</div>
					<div>This page has been accessed 10,541 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.036},"limitreport":{"cputime":"0.480","walltime":"3.792","ppvisitednodes":{"value":2081,"limit":1000000},"postexpandincludesize":{"value":7581,"limit":2097152},"templateargumentsize":{"value":2166,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":58030,"limit":5000000},"timingprofile":["100.00% 1022.181      1 Template:Article","100.00% 1022.181      1 -total"," 89.85%  918.415      4 Template:Infobox_section"," 14.49%  148.096      6 Template:UserLookup","  2.99%   30.523      1 Template:Review_expired","  2.22%   22.733      1 Template:Get_active_contest","  1.30%   13.293      1 Template:Infobox_begin","  0.09%    0.927      1 Template:Infobox_end"]},"cachereport":{"timestamp":"20230306035200","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":4575});});</script></body>
</html>